Details of the Drug Combinations

General Information of This Drug (ID: DMUOT9V)

Drug Name

Taxol DMUOT9V

Synonyms

C47H51NO14; weekly paclitaxel; Micellar Paclitaxel; Paclitaxel [USAN:INN:BAN]; SCHEMBL15000506; Benzenepropanoic acid, beta-(benzoylamino)-alpha-hydroxy-, 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester, (2aR-(2aalpha,4beta,4abeta,6beta,9alpha(alphaR*,betaS*),11alpha,12alpha,12aalpha,12balpha))-

Indication

Disease Entry	ICD 11	Status	REF
Breast cancer	2C60-2C65	Approved	[1]
Solid tumour/cancer	2A00-2F9Z	Approved	[2]
Pancreatic cancer	2C10	Phase 3	[3]
Gastric adenocarcinoma	2B72	Phase 2	[4]
Ovarian cancer	2C73	Phase 2	[4]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL is unavailable

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

917 Investigative Drug Combination(s) Consisting of This drug

Normalized Drug Combination Synergy Score

Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
ABIRATERONE + Taxol	DCAQ75W	ABIRATERONE	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[5]
ABIRATERONE + Taxol	DC8SVDT	ABIRATERONE	Anaplastic large cell lymphoma (Cell Line: SR)	[5]
ABIRATERONE + Taxol	DCCC1G3	ABIRATERONE	Astrocytoma (Cell Line: U251)	[5]
ABIRATERONE + Taxol	DCM6LCX	ABIRATERONE	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[5]
ABIRATERONE + Taxol	DCKDSR0	ABIRATERONE	Clear cell renal cell carcinoma (Cell Line: 786-0)	[5]
ABIRATERONE + Taxol	DC0P0EW	ABIRATERONE	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[5]
ABIRATERONE + Taxol	DCUH30M	ABIRATERONE	Glioma (Cell Line: SF-295)	[5]
ABIRATERONE + Taxol	DCMIERP	ABIRATERONE	Plasma cell myeloma (Cell Line: RPMI-8226)	[5]
ABIRATERONE + Taxol	DCMMSI0	ABIRATERONE	Renal cell carcinoma (Cell Line: UO-31)	[5]
ABIRATERONE + Taxol	DCI97DE	ABIRATERONE	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[6]
ABIRATERONE + Taxol	DCE9HYZ	ABIRATERONE	Carcinoma (Cell Line: RXF 393)	[6]
ABIRATERONE + Taxol	DCSCRU4	ABIRATERONE	Carcinoma (Cell Line: MCF7)	[6]
ABIRATERONE + Taxol	DCADALD	ABIRATERONE	Colon carcinoma (Cell Line: KM12)	[6]
ABIRATERONE + Taxol	DCBXX2Y	ABIRATERONE	Adenocarcinoma (Cell Line: OVCAR3)	[7]
ABIRATERONE + Taxol	DC9AXO9	ABIRATERONE	Adenocarcinoma (Cell Line: A549)	[7]
ABIRATERONE + Taxol	DC8FO7S	ABIRATERONE	Adenocarcinoma (Cell Line: SW-620)	[7]
ABIRATERONE + Taxol	DCTZV6G	ABIRATERONE	Adenocarcinoma (Cell Line: HCT116)	[7]
ABIRATERONE + Taxol	DC6X86K	ABIRATERONE	Adenocarcinoma (Cell Line: HCT-15)	[7]
ABIRATERONE + Taxol	DCGX9OK	ABIRATERONE	Adenocarcinoma (Cell Line: HCC-2998)	[7]
ABIRATERONE + Taxol	DCCLVLM	ABIRATERONE	Adenocarcinoma (Cell Line: HT29)	[7]
ABIRATERONE + Taxol	DCXBDK2	ABIRATERONE	Amelanotic melanoma (Cell Line: MDA-MB-435)	[7]
ABIRATERONE + Taxol	DCSLWNE	ABIRATERONE	Amelanotic melanoma (Cell Line: M14)	[7]
ABIRATERONE + Taxol	DCFKLXA	ABIRATERONE	Cutaneous melanoma (Cell Line: SK-MEL-28)	[7]
ABIRATERONE + Taxol	DCVPQMO	ABIRATERONE	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[7]
ABIRATERONE + Taxol	DCUM32Y	ABIRATERONE	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[7]
ABIRATERONE + Taxol	DCQXIZ0	ABIRATERONE	Lung adenocarcinoma (Cell Line: NCI-H522)	[7]
ABIRATERONE + Taxol	DCK0Q71	ABIRATERONE	Malignant melanoma (Cell Line: LOX IMVI)	[7]
ABIRATERONE + Taxol	DC0GFIV	ABIRATERONE	Melanoma (Cell Line: MALME-3M)	[7]
ABIRATERONE + Taxol	DCLZ8J5	ABIRATERONE	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[7]
ABIRATERONE + Taxol	DCJ5QOS	ABIRATERONE	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[7]
Amonafide + Taxol	DC05JUS	Amonafide	Adenocarcinoma (Cell Line: NCIH23)	[5]
Amonafide + Taxol	DCXI4FL	Amonafide	Adenocarcinoma (Cell Line: HCT-15)	[5]
Amonafide + Taxol	DCQPDNN	Amonafide	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[5]
Amonafide + Taxol	DCJ4EQ2	Amonafide	Astrocytoma (Cell Line: U251)	[5]
Amonafide + Taxol	DCRYZ9N	Amonafide	Chronic myelogenous leukemia (Cell Line: K-562)	[5]
Amonafide + Taxol	DCA10N3	Amonafide	Lung adenocarcinoma (Cell Line: HOP-62)	[5]
Amonafide + Taxol	DC59TQ3	Amonafide	Colon adenocarcinoma (Cell Line: COLO 205)	[6]
Anastrozole + Taxol	DC3OQNA	Anastrozole	Adenocarcinoma (Cell Line: SW-620)	[5]
Anastrozole + Taxol	DC2IHHF	Anastrozole	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[5]
Anastrozole + Taxol	DC0BGVB	Anastrozole	Colon adenocarcinoma (Cell Line: COLO 205)	[6]
BIO-300 + Taxol	DCL6C1X	BIO-300	Chronic myelogenous leukemia (Cell Line: K-562)	[5]
BIO-300 + Taxol	DCVHWRA	BIO-300	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[5]
BIO-300 + Taxol	DCN4EVW	BIO-300	Glioma (Cell Line: SF-268)	[5]
BIO-300 + Taxol	DCV4AKS	BIO-300	Colon adenocarcinoma (Cell Line: COLO 205)	[6]
BIO-300 + Taxol	DC8O7QJ	BIO-300	Adenocarcinoma (Cell Line: NCIH23)	[7]
BIO-300 + Taxol	DCUNE2M	BIO-300	Adenocarcinoma (Cell Line: HCT-15)	[7]
BIO-300 + Taxol	DCXZUCT	BIO-300	Adenocarcinoma (Cell Line: SW-620)	[7]
BIO-300 + Taxol	DCN4156	BIO-300	Cutaneous melanoma (Cell Line: SK-MEL-28)	[7]
BIO-300 + Taxol	DC8B9L6	BIO-300	Lung adenocarcinoma (Cell Line: HOP-62)	[7]
Cabazitaxel + Taxol	DC7A0VU	Cabazitaxel	Adenocarcinoma (Cell Line: DU-145)	[5]
Cabazitaxel + Taxol	DCN2YLS	Cabazitaxel	Adenocarcinoma (Cell Line: OVCAR3)	[5]
Cabazitaxel + Taxol	DCDN3AY	Cabazitaxel	Adenocarcinoma (Cell Line: A549)	[5]
Cabazitaxel + Taxol	DC9YC2R	Cabazitaxel	Adenocarcinoma (Cell Line: HCT-15)	[5]
Cabazitaxel + Taxol	DCZKB1U	Cabazitaxel	Adenocarcinoma (Cell Line: HCC-2998)	[5]
Cabazitaxel + Taxol	DCC35YQ	Cabazitaxel	Adenocarcinoma (Cell Line: HCT116)	[5]
Cabazitaxel + Taxol	DCA7QKW	Cabazitaxel	Adenocarcinoma (Cell Line: HT29)	[5]
Cabazitaxel + Taxol	DCQLY2Z	Cabazitaxel	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[5]
Cabazitaxel + Taxol	DC6EILQ	Cabazitaxel	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[5]
Cabazitaxel + Taxol	DCVGJUQ	Cabazitaxel	Anaplastic large cell lymphoma (Cell Line: SR)	[5]
Cabazitaxel + Taxol	DCWDW2Q	Cabazitaxel	Astrocytoma (Cell Line: U251)	[5]
Cabazitaxel + Taxol	DC9XKWP	Cabazitaxel	Astrocytoma (Cell Line: SNB-19)	[5]
Cabazitaxel + Taxol	DC6YHW8	Cabazitaxel	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[5]
Cabazitaxel + Taxol	DC0EFYW	Cabazitaxel	Clear cell renal cell carcinoma (Cell Line: A498)	[5]
Cabazitaxel + Taxol	DCO0RUF	Cabazitaxel	Clear cell renal cell carcinoma (Cell Line: 786-0)	[5]
Cabazitaxel + Taxol	DCDLOIO	Cabazitaxel	Cutaneous melanoma (Cell Line: SK-MEL-5)	[5]
Cabazitaxel + Taxol	DCACEGM	Cabazitaxel	Glioma (Cell Line: SF-539)	[5]
Cabazitaxel + Taxol	DCO5OWV	Cabazitaxel	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)	[5]
Cabazitaxel + Taxol	DCEXYHR	Cabazitaxel	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[5]
Cabazitaxel + Taxol	DCO0VXH	Cabazitaxel	Large cell lung carcinoma (Cell Line: NCI-H460)	[5]
Cabazitaxel + Taxol	DCZ0FKH	Cabazitaxel	Lung adenocarcinoma (Cell Line: NCI-H522)	[5]
Cabazitaxel + Taxol	DCHZH8U	Cabazitaxel	Malignant melanoma (Cell Line: LOX IMVI)	[5]
Cabazitaxel + Taxol	DC5D0RI	Cabazitaxel	Malignant melanoma (Cell Line: UACC62)	[5]
Cabazitaxel + Taxol	DCNCX28	Cabazitaxel	Melanoma (Cell Line: UACC-257)	[5]
Cabazitaxel + Taxol	DCJQUQ1	Cabazitaxel	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[5]
Cabazitaxel + Taxol	DCNJEWA	Cabazitaxel	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[5]
Cabazitaxel + Taxol	DC5PWQP	Cabazitaxel	Plasma cell myeloma (Cell Line: RPMI-8226)	[5]
Cabazitaxel + Taxol	DC2BZCV	Cabazitaxel	Prostate carcinoma (Cell Line: PC-3)	[5]
Cabazitaxel + Taxol	DCPHLFE	Cabazitaxel	Renal cell carcinoma (Cell Line: SN12C)	[5]
Cabazitaxel + Taxol	DCFU6FC	Cabazitaxel	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[6]
Cabazitaxel + Taxol	DCNMEQ2	Cabazitaxel	Carcinoma (Cell Line: RXF 393)	[6]
Cabazitaxel + Taxol	DCHMBJR	Cabazitaxel	Carcinoma (Cell Line: MCF7)	[6]
Cabazitaxel + Taxol	DCPPW3P	Cabazitaxel	Colon carcinoma (Cell Line: KM12)	[6]
Cabazitaxel + Taxol	DCPT8ZY	Cabazitaxel	Invasive ductal carcinoma (Cell Line: T-47D)	[6]
Cabazitaxel + Taxol	DCMWD3I	Cabazitaxel	Invasive ductal carcinoma (Cell Line: BT-549)	[6]
Cabazitaxel + Taxol	DCS3GV7	Cabazitaxel	Invasive ductal carcinoma (Cell Line: HS 578T)	[6]
Crizotinib + Taxol	DCI36BQ	Crizotinib	Adenocarcinoma (Cell Line: HT29)	[5]
Crizotinib + Taxol	DC4MCSE	Crizotinib	Adenocarcinoma (Cell Line: HCT-15)	[5]
Crizotinib + Taxol	DC7B59L	Crizotinib	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[5]
Crizotinib + Taxol	DC7Y8TD	Crizotinib	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[5]
Crizotinib + Taxol	DCRBMUZ	Crizotinib	Anaplastic large cell lymphoma (Cell Line: SR)	[5]
Crizotinib + Taxol	DCBTU2H	Crizotinib	Clear cell renal cell carcinoma (Cell Line: TK-10)	[5]
Crizotinib + Taxol	DC1XZQ3	Crizotinib	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[5]
Crizotinib + Taxol	DCQ2AER	Crizotinib	Malignant melanoma (Cell Line: LOX IMVI)	[5]
Crizotinib + Taxol	DCSEUSO	Crizotinib	Malignant melanoma (Cell Line: UACC62)	[5]
Crizotinib + Taxol	DCT6P38	Crizotinib	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[5]
Dactinomycin + Taxol	DCIFR25	Dactinomycin	Colon adenocarcinoma (Cell Line: COLO 205)	[6]
Dactinomycin + Taxol	DCCQ3YC	Dactinomycin	Invasive ductal carcinoma (Cell Line: BT-549)	[6]
Dactinomycin + Taxol	DC4YCQY	Dactinomycin	Invasive ductal carcinoma (Cell Line: HS 578T)	[6]
Dactinomycin + Taxol	DCDXFL0	Dactinomycin	Adenocarcinoma (Cell Line: OVCAR3)	[7]
Dactinomycin + Taxol	DC6KDZN	Dactinomycin	Adenocarcinoma (Cell Line: HCC-2998)	[7]
Dactinomycin + Taxol	DC44KJH	Dactinomycin	Adenocarcinoma (Cell Line: SW-620)	[7]
Dactinomycin + Taxol	DCL4THS	Dactinomycin	Adenocarcinoma (Cell Line: HCT-15)	[7]
Dactinomycin + Taxol	DC1CQGT	Dactinomycin	Anaplastic large cell lymphoma (Cell Line: SR)	[7]
Dactinomycin + Taxol	DCZ4V1Z	Dactinomycin	Glioma (Cell Line: SF-539)	[7]
Dactinomycin + Taxol	DCK6IXJ	Dactinomycin	Large cell lung carcinoma (Cell Line: NCI-H460)	[7]
Dactinomycin + Taxol	DCDQIF7	Dactinomycin	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[7]
Dactinomycin + Taxol	DCLW7D6	Dactinomycin	Plasma cell myeloma (Cell Line: RPMI-8226)	[7]
DFN-15 + Taxol	DCPI08Q	DFN-15	Astrocytoma (Cell Line: U251)	[5]
DFN-15 + Taxol	DCSNZAC	DFN-15	Clear cell renal cell carcinoma (Cell Line: 786-0)	[5]
DFN-15 + Taxol	DCGNPDY	DFN-15	Clear cell renal cell carcinoma (Cell Line: A498)	[5]
DFN-15 + Taxol	DCSXDDC	DFN-15	Glioblastoma (Cell Line: SNB-75)	[5]
DFN-15 + Taxol	DCB0A4D	DFN-15	Glioma (Cell Line: SF-268)	[5]
DFN-15 + Taxol	DC9MBVJ	DFN-15	Glioma (Cell Line: SF-295)	[5]
DFN-15 + Taxol	DC3T71J	DFN-15	Renal cell carcinoma (Cell Line: UO-31)	[5]
DFN-15 + Taxol	DCRKTDX	DFN-15	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[6]
DFN-15 + Taxol	DCOOPCN	DFN-15	Colon carcinoma (Cell Line: KM12)	[6]
DFN-15 + Taxol	DCI1ARZ	DFN-15	Invasive ductal carcinoma (Cell Line: BT-549)	[6]
DFN-15 + Taxol	DC0J66X	DFN-15	Adenocarcinoma (Cell Line: HT29)	[7]
DFN-15 + Taxol	DCL1G2S	DFN-15	Large cell lung carcinoma (Cell Line: NCI-H460)	[7]
DFN-15 + Taxol	DCFSRKM	DFN-15	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[7]
DFN-15 + Taxol	DCJCY6M	DFN-15	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[7]
DFN-15 + Taxol	DC7IV5F	DFN-15	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
DFN-15 + Taxol	DCOMFQQ	DFN-15	Prostate carcinoma (Cell Line: PC-3)	[7]
Digitoxin + Taxol	DC67E0P	Digitoxin	Chronic myelogenous leukemia (Cell Line: K-562)	[5]
Digitoxin + Taxol	DCC486V	Digitoxin	Glioma (Cell Line: SF-295)	[5]
Digitoxin + Taxol	DC9R1VC	Digitoxin	Plasma cell myeloma (Cell Line: RPMI-8226)	[5]
Digitoxin + Taxol	DC3OA1H	Digitoxin	Invasive ductal carcinoma (Cell Line: HS 578T)	[6]
Epirubicin + Taxol	DCOO8OO	Epirubicin	Astrocytoma (Cell Line: U251)	[5]
Epirubicin + Taxol	DC5CD0U	Epirubicin	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[5]
Epirubicin + Taxol	DCVQ45F	Epirubicin	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[5]
Epirubicin + Taxol	DCYMAWR	Epirubicin	Glioma (Cell Line: SF-295)	[5]
Epirubicin + Taxol	DC1NAA6	Epirubicin	Papillary renal cell carcinoma (Cell Line: ACHN)	[5]
Epirubicin + Taxol	DCZ0740	Epirubicin	Renal cell carcinoma (Cell Line: UO-31)	[5]
Epirubicin + Taxol	DCJNULN	Epirubicin	Adenocarcinoma (Cell Line: A549)	[7]
Epirubicin + Taxol	DC60EOV	Epirubicin	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[7]
Epirubicin + Taxol	DCH5CY0	Epirubicin	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[7]
Fludarabine + Taxol	DCF0T6F	Fludarabine	Adenocarcinoma (Cell Line: HT29)	[7]
Fluorouracil + Taxol	DCI2O36	Fluorouracil	Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)	[5]
Fluorouracil + Taxol	DCTE1J7	Fluorouracil	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[6]
Fluorouracil + Taxol	DC67GFZ	Fluorouracil	Breast carcinoma (Cell Line: OCUBM)	[6]
Fluorouracil + Taxol	DC10K8O	Fluorouracil	Carcinoma (Cell Line: OV90)	[6]
Fluorouracil + Taxol	DC3A7DU	Fluorouracil	Colon adenocarcinoma (Cell Line: LOVO)	[6]
Fluorouracil + Taxol	DC0JHJB	Fluorouracil	Colon carcinoma (Cell Line: RKO)	[6]
Fluorouracil + Taxol	DCC6H99	Fluorouracil	Invasive ductal carcinoma (Cell Line: T-47D)	[6]
Fluorouracil + Taxol	DCKDNVO	Fluorouracil	Rectal adenocarcinoma (Cell Line: SW837)	[6]
Fluorouracil + Taxol	DCEC8CX	Fluorouracil	Adenocarcinoma (Cell Line: CAOV3)	[7]
Fluorouracil + Taxol	DCIRXH1	Fluorouracil	Adenocarcinoma (Cell Line: OVCAR3)	[7]
Fluorouracil + Taxol	DC9W2G0	Fluorouracil	Adenocarcinoma (Cell Line: A427)	[7]
Fluorouracil + Taxol	DCB9UB3	Fluorouracil	Adenocarcinoma (Cell Line: NCIH23)	[7]
Fluorouracil + Taxol	DCEZRBQ	Fluorouracil	Adenocarcinoma (Cell Line: NCIH520)	[7]
Fluorouracil + Taxol	DC05QNU	Fluorouracil	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Fluorouracil + Taxol	DCILUE1	Fluorouracil	Adenocarcinoma (Cell Line: DLD1)	[7]
Fluorouracil + Taxol	DCAP35Z	Fluorouracil	Adenocarcinoma (Cell Line: HCT116)	[7]
Fluorouracil + Taxol	DC4WJKZ	Fluorouracil	Adenocarcinoma (Cell Line: HT29)	[7]
Fluorouracil + Taxol	DCNQGE1	Fluorouracil	Germ cell tumour (Cell Line: PA1)	[7]
Fluorouracil + Taxol	DCNZOVJ	Fluorouracil	Large cell lung carcinoma (Cell Line: NCI-H460)	[7]
Fluorouracil + Taxol	DCEZPA1	Fluorouracil	Malignant melanoma (Cell Line: A375)	[7]
Fluorouracil + Taxol	DC0INP8	Fluorouracil	Malignant melanoma (Cell Line: HT144)	[7]
Fluorouracil + Taxol	DCDVT1R	Fluorouracil	Malignant melanoma (Cell Line: RPMI7951)	[7]
Fluorouracil + Taxol	DCX4ZV9	Fluorouracil	Malignant melanoma (Cell Line: SKMEL30)	[7]
Fluorouracil + Taxol	DC8JPSR	Fluorouracil	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Fluorouracil + Taxol	DC334CL	Fluorouracil	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Gefitinib + Taxol	DCMU31W	Gefitinib	Adenocarcinoma (Cell Line: OVCAR3)	[5]
Gefitinib + Taxol	DC2LB27	Gefitinib	Adenocarcinoma (Cell Line: NCIH23)	[5]
Gefitinib + Taxol	DCXRCQP	Gefitinib	Adenocarcinoma (Cell Line: SW-620)	[5]
Gefitinib + Taxol	DCHSVM0	Gefitinib	Astrocytoma (Cell Line: U251)	[5]
Gefitinib + Taxol	DC79M7N	Gefitinib	Astrocytoma (Cell Line: SNB-19)	[5]
Gefitinib + Taxol	DC99NY1	Gefitinib	Cutaneous melanoma (Cell Line: SK-MEL-5)	[5]
Gefitinib + Taxol	DC9MBA7	Gefitinib	Glioma (Cell Line: SF-295)	[5]
Gefitinib + Taxol	DCP80Y8	Gefitinib	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[5]
Gefitinib + Taxol	DCJ7GTZ	Gefitinib	Melanoma (Cell Line: MALME-3M)	[5]
Gefitinib + Taxol	DC77632	Gefitinib	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[5]
Gefitinib + Taxol	DCRJD8Z	Gefitinib	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[5]
Gefitinib + Taxol	DCDB76A	Gefitinib	Carcinoma (Cell Line: RXF 393)	[6]
Gefitinib + Taxol	DCWNTDI	Gefitinib	Colon carcinoma (Cell Line: KM12)	[6]
Hepzato + Taxol	DCPBRV7	Hepzato	Astrocytoma (Cell Line: U251)	[5]
Hepzato + Taxol	DC80PVU	Hepzato	Glioma (Cell Line: SF-295)	[5]
Idarubicin + Taxol	DCTHSO7	Idarubicin	Glioma (Cell Line: SF-295)	[5]
Imatinib + Taxol	DCLF0MP	Imatinib	Adenocarcinoma (Cell Line: HT29)	[5]
Imatinib + Taxol	DCO5HTD	Imatinib	Adenocarcinoma (Cell Line: HCT-15)	[5]
Imatinib + Taxol	DCFXXLX	Imatinib	Adenocarcinoma (Cell Line: HCC-2998)	[5]
Imatinib + Taxol	DCLFN0G	Imatinib	Chronic myelogenous leukemia (Cell Line: K-562)	[5]
Imatinib + Taxol	DC4CQKF	Imatinib	Clear cell renal cell carcinoma (Cell Line: 786-0)	[5]
Imatinib + Taxol	DCW3XFA	Imatinib	Glioblastoma (Cell Line: SNB-75)	[5]
Imatinib + Taxol	DCXYNHW	Imatinib	Glioma (Cell Line: SF-295)	[5]
Imatinib + Taxol	DC0BH3K	Imatinib	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[5]
Imatinib + Taxol	DC08OS5	Imatinib	Large cell lung carcinoma (Cell Line: NCI-H460)	[5]
Imatinib + Taxol	DCMVKBW	Imatinib	Renal cell carcinoma (Cell Line: UO-31)	[5]
Indazole derivative 5 + Taxol	DCHDEOI	Indazole derivative 5	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[5]
Indazole derivative 5 + Taxol	DC1BPVF	Indazole derivative 5	Anaplastic large cell lymphoma (Cell Line: SR)	[5]
Indazole derivative 5 + Taxol	DCBIA53	Indazole derivative 5	Astrocytoma (Cell Line: U251)	[5]
Indazole derivative 5 + Taxol	DC85OCH	Indazole derivative 5	Astrocytoma (Cell Line: SNB-19)	[5]
Indazole derivative 5 + Taxol	DCI2YLE	Indazole derivative 5	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[5]
Indazole derivative 5 + Taxol	DCZAYAR	Indazole derivative 5	Glioma (Cell Line: SF-539)	[5]
Indazole derivative 5 + Taxol	DC8RCVM	Indazole derivative 5	Colon carcinoma (Cell Line: KM12)	[6]
Indazole derivative 5 + Taxol	DC1KST3	Indazole derivative 5	Adenocarcinoma (Cell Line: A549)	[7]
Indazole derivative 5 + Taxol	DCUHXAD	Indazole derivative 5	Adenocarcinoma (Cell Line: HCC-2998)	[7]
Indazole derivative 5 + Taxol	DC33V27	Indazole derivative 5	Adenocarcinoma (Cell Line: HCT-15)	[7]
Indazole derivative 5 + Taxol	DCRFBF0	Indazole derivative 5	Amelanotic melanoma (Cell Line: MDA-MB-435)	[7]
Indazole derivative 5 + Taxol	DCJJQDP	Indazole derivative 5	Malignant melanoma (Cell Line: UACC62)	[7]
LIAROZOLE + Taxol	DCRLXD7	LIAROZOLE	Glioma (Cell Line: SF-268)	[5]
LIAROZOLE + Taxol	DCZP0WZ	LIAROZOLE	Invasive ductal carcinoma (Cell Line: BT-549)	[6]
LIAROZOLE + Taxol	DCN40PB	LIAROZOLE	Invasive ductal carcinoma (Cell Line: HS 578T)	[6]
LIAROZOLE + Taxol	DCOWBQL	LIAROZOLE	Large cell lung carcinoma (Cell Line: NCI-H460)	[7]
LIAROZOLE + Taxol	DCNT4R5	LIAROZOLE	Malignant melanoma (Cell Line: UACC62)	[7]
Nilotinib + Taxol	DCTY7MW	Nilotinib	Astrocytoma (Cell Line: U251)	[5]
Nilotinib + Taxol	DC6VYWA	Nilotinib	Glioblastoma (Cell Line: SNB-75)	[5]
Nilotinib + Taxol	DC59P66	Nilotinib	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[6]
Nilotinib + Taxol	DCEVOEU	Nilotinib	Invasive ductal carcinoma (Cell Line: HS 578T)	[6]
Nilotinib + Taxol	DCX1JG0	Nilotinib	Invasive ductal carcinoma (Cell Line: BT-549)	[6]
Nilotinib + Taxol	DCXUS2P	Nilotinib	Malignant melanoma (Cell Line: LOX IMVI)	[7]
Ruxolitinib + Taxol	DCWQ7X1	Ruxolitinib	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[5]
Ruxolitinib + Taxol	DCJWWB6	Ruxolitinib	Anaplastic large cell lymphoma (Cell Line: SR)	[5]
Ruxolitinib + Taxol	DCY2CPL	Ruxolitinib	Clear cell renal cell carcinoma (Cell Line: A498)	[5]
Ruxolitinib + Taxol	DCI9JK1	Ruxolitinib	Carcinoma (Cell Line: RXF 393)	[6]
Ruxolitinib + Taxol	DCUYCP5	Ruxolitinib	Carcinoma (Cell Line: MCF7)	[6]
Ruxolitinib + Taxol	DCNI0Q0	Ruxolitinib	Colon carcinoma (Cell Line: KM12)	[6]
Ruxolitinib + Taxol	DCNAFFC	Ruxolitinib	Adenocarcinoma (Cell Line: DU-145)	[7]
Ruxolitinib + Taxol	DCB8KTB	Ruxolitinib	Adenocarcinoma (Cell Line: A549)	[7]
Ruxolitinib + Taxol	DC0I0NI	Ruxolitinib	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[7]
Ruxolitinib + Taxol	DCPDN0J	Ruxolitinib	Lung adenocarcinoma (Cell Line: NCI-H522)	[7]
Ruxolitinib + Taxol	DCTW0K0	Ruxolitinib	Malignant melanoma (Cell Line: LOX IMVI)	[7]
Ruxolitinib + Taxol	DC5AWHY	Ruxolitinib	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[7]
Sirolimus + Taxol	DCH0Y3V	Sirolimus	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[5]
Sirolimus + Taxol	DC8HHAD	Sirolimus	Astrocytoma (Cell Line: U251)	[5]
Sirolimus + Taxol	DCY7BQO	Sirolimus	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[5]
Sirolimus + Taxol	DC00QAS	Sirolimus	Glioma (Cell Line: SF-539)	[5]
Sirolimus + Taxol	DCBBPMX	Sirolimus	Renal cell carcinoma (Cell Line: UO-31)	[5]
Sirolimus + Taxol	DCUFNAI	Sirolimus	Colon adenocarcinoma (Cell Line: COLO 205)	[6]
Sirolimus + Taxol	DCBTOIF	Sirolimus	Colon carcinoma (Cell Line: KM12)	[6]
Sirolimus + Taxol	DCEKHM8	Sirolimus	Adenocarcinoma (Cell Line: OVCAR3)	[7]
Sirolimus + Taxol	DCT7GMB	Sirolimus	Adenocarcinoma (Cell Line: A549)	[7]
Sirolimus + Taxol	DCSJH1I	Sirolimus	Cutaneous melanoma (Cell Line: SK-MEL-28)	[7]
Sirolimus + Taxol	DCIRFB0	Sirolimus	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[7]
Sirolimus + Taxol	DCRTI8O	Sirolimus	Large cell lung carcinoma (Cell Line: NCI-H460)	[7]
Sirolimus + Taxol	DCG1VQV	Sirolimus	Malignant melanoma (Cell Line: LOX IMVI)	[7]
Sirolimus + Taxol	DCTSNDQ	Sirolimus	Melanoma (Cell Line: MALME-3M)	[7]
Sirolimus + Taxol	DCZWOXB	Sirolimus	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[7]
Sirolimus + Taxol	DCTGG31	Sirolimus	Prostate carcinoma (Cell Line: PC-3)	[7]
SY-1425 + Taxol	DCUHV1X	SY-1425	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[5]
SY-1425 + Taxol	DC46IBE	SY-1425	Chronic myelogenous leukemia (Cell Line: K-562)	[5]
SY-1425 + Taxol	DCEUG0B	SY-1425	Clear cell renal cell carcinoma (Cell Line: A498)	[5]
SY-1425 + Taxol	DCTY9JT	SY-1425	Clear cell renal cell carcinoma (Cell Line: 786-0)	[5]
SY-1425 + Taxol	DCK4XFJ	SY-1425	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[5]
SY-1425 + Taxol	DCDPXWY	SY-1425	Glioblastoma (Cell Line: SNB-75)	[5]
SY-1425 + Taxol	DCIJ8WD	SY-1425	Glioma (Cell Line: SF-295)	[5]
SY-1425 + Taxol	DC9FD1U	SY-1425	Glioma (Cell Line: SF-268)	[5]
SY-1425 + Taxol	DCGF0X1	SY-1425	Papillary renal cell carcinoma (Cell Line: ACHN)	[5]
SY-1425 + Taxol	DCJMAX6	SY-1425	Plasma cell myeloma (Cell Line: RPMI-8226)	[5]
SY-1425 + Taxol	DCB5EZV	SY-1425	Renal cell carcinoma (Cell Line: UO-31)	[5]
SY-1425 + Taxol	DC4WN0A	SY-1425	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[6]
SY-1425 + Taxol	DC60YAW	SY-1425	Carcinoma (Cell Line: MCF7)	[6]
SY-1425 + Taxol	DCSZ8BO	SY-1425	Colon carcinoma (Cell Line: KM12)	[6]
SY-1425 + Taxol	DCQP3LK	SY-1425	Invasive ductal carcinoma (Cell Line: BT-549)	[6]
SY-1425 + Taxol	DCAMS9D	SY-1425	Invasive ductal carcinoma (Cell Line: HS 578T)	[6]
SY-1425 + Taxol	DCK989Q	SY-1425	Invasive ductal carcinoma (Cell Line: T-47D)	[6]
SY-1425 + Taxol	DCAA956	SY-1425	Adenocarcinoma (Cell Line: A549)	[7]
SY-1425 + Taxol	DCCN6KQ	SY-1425	Adenocarcinoma (Cell Line: HCC-2998)	[7]
SY-1425 + Taxol	DCA89CV	SY-1425	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[7]
SY-1425 + Taxol	DCG9FXT	SY-1425	Large cell lung carcinoma (Cell Line: NCI-H460)	[7]
SY-1425 + Taxol	DCS6OK2	SY-1425	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[7]
SY-1425 + Taxol	DCX9A17	SY-1425	Melanoma (Cell Line: MALME-3M)	[7]
SY-1425 + Taxol	DCDX22C	SY-1425	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[7]
SY-1425 + Taxol	DCKS9T0	SY-1425	Prostate carcinoma (Cell Line: PC-3)	[7]
Taxol + Fulvestrant	DCHUH7F	Fulvestrant	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[5]
Taxol + PD-0325901	DCUOD8R	PD-0325901	Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)	[5]
Taxol + LY335979	DC4ZKX4	LY335979	Human papillomavirus-related cervical adenocarcinoma (Cell Line: KB-ChR-8-5-11)	[5]
Taxol + Ixabepilone	DCEQJX2	Ixabepilone	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[5]
Taxol + Ixabepilone	DC797B8	Ixabepilone	Astrocytoma (Cell Line: SNB-19)	[5]
Taxol + Ixabepilone	DCFS6SN	Ixabepilone	Chronic myelogenous leukemia (Cell Line: K-562)	[5]
Taxol + Ixabepilone	DCQ3I8Q	Ixabepilone	Glioma (Cell Line: SF-539)	[5]
Taxol + Ixabepilone	DC8QC3O	Ixabepilone	Renal cell carcinoma (Cell Line: SN12C)	[5]
Taxol + Lapatinib	DCFAQVG	Lapatinib	Anaplastic large cell lymphoma (Cell Line: SR)	[5]
Taxol + Lapatinib	DCV0Q5W	Lapatinib	Clear cell renal cell carcinoma (Cell Line: A498)	[5]
Taxol + Lapatinib	DC44E08	Lapatinib	Clear cell renal cell carcinoma (Cell Line: 786-0)	[5]
Taxol + Lapatinib	DCNGZEB	Lapatinib	Clear cell renal cell carcinoma (Cell Line: TK-10)	[5]
Taxol + Lapatinib	DC5MN3U	Lapatinib	Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)	[5]
Taxol + Lapatinib	DCX0X37	Lapatinib	Glioblastoma (Cell Line: SNB-75)	[5]
Taxol + Lapatinib	DCFPA2G	Lapatinib	Glioma (Cell Line: SF-295)	[5]
Taxol + Lapatinib	DC20JTY	Lapatinib	Papillary renal cell carcinoma (Cell Line: ACHN)	[5]
Taxol + Lapatinib	DCDM6OT	Lapatinib	Renal cell carcinoma (Cell Line: UO-31)	[5]
Taxol + Lapatinib	DCDCVOV	Lapatinib	Renal cell carcinoma (Cell Line: SN12C)	[5]
Taxol + MK-1775	DCOZ0EB	MK-1775	Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)	[5]
Taxol + PMID28460551-Compound-2	DCW0TM4	PMID28460551-Compound-2	Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)	[5]
Taxol + Cyclophosphamide	DC4ZEP4	Cyclophosphamide	Renal cell carcinoma (Cell Line: UO-31)	[5]
Taxol + Arsenic trioxide	DCUH2IK	Arsenic trioxide	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[5]
Taxol + Arsenic trioxide	DCQ09OO	Arsenic trioxide	Glioblastoma (Cell Line: SNB-75)	[5]
Taxol + RTB101	DCVRHE9	RTB101	Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)	[5]
Taxol + SCH-900776	DCEW2SX	SCH-900776	Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)	[5]
Taxol + Plicamycin	DCYHN6O	Plicamycin	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[5]
Taxol + Plicamycin	DCSXTP0	Plicamycin	Anaplastic large cell lymphoma (Cell Line: SR)	[5]
Taxol + Plicamycin	DCDC5O7	Plicamycin	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[5]
Taxol + Plicamycin	DCMJOXQ	Plicamycin	Chronic myelogenous leukemia (Cell Line: K-562)	[5]
Taxol + Plicamycin	DCL4Z7F	Plicamycin	Clear cell renal cell carcinoma (Cell Line: A498)	[5]
Taxol + Plicamycin	DCKW2MV	Plicamycin	Glioblastoma (Cell Line: SNB-75)	[5]
Taxol + Plicamycin	DCSIN75	Plicamycin	Glioma (Cell Line: SF-539)	[5]
Taxol + Plicamycin	DC3XFH5	Plicamycin	Plasma cell myeloma (Cell Line: RPMI-8226)	[5]
Taxol + Triapine	DC9EQTZ	Triapine	Clear cell renal cell carcinoma (Cell Line: TK-10)	[5]
Taxol + 10-hydroxycamptothecin	DCP1XFT	10-hydroxycamptothecin	Glioma (Cell Line: SF-539)	[5]
Taxol + Topetecan	DCA4FNV	Topetecan	Astrocytoma (Cell Line: SNB-19)	[5]
Taxol + Topetecan	DCOHVZ3	Topetecan	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[5]
Taxol + Topetecan	DCL9ER5	Topetecan	Glioma (Cell Line: SF-539)	[5]
Taxol + Pralatrexate	DCUGUQO	Pralatrexate	Astrocytoma (Cell Line: SNB-19)	[5]
Taxol + Pralatrexate	DCX7J5N	Pralatrexate	Chronic myelogenous leukemia (Cell Line: K-562)	[5]
Taxol + SNX-2112	DCR57AE	SNX-2112	Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)	[5]
Taxol + Terameprocol	DC08I6Q	Terameprocol	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[5]
Taxol + Terameprocol	DC3PRJN	Terameprocol	Glioma (Cell Line: SF-539)	[5]
Taxol + SCH 727965	DC8CYQJ	SCH 727965	Anaplastic large cell lymphoma (Cell Line: SR)	[5]
Taxol + SCH 727965	DCZSJPL	SCH 727965	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[5]
Taxol + SCH 727965	DCDGE1S	SCH 727965	Chronic myelogenous leukemia (Cell Line: K-562)	[5]
Taxol + SCH 727965	DC4ICDI	SCH 727965	Clear cell renal cell carcinoma (Cell Line: 786-0)	[5]
Taxol + SCH 727965	DCJQ765	SCH 727965	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[5]
Taxol + SCH 727965	DC5WLVV	SCH 727965	Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)	[5]
Taxol + SCH 727965	DCRLJPR	SCH 727965	Glioblastoma (Cell Line: SNB-75)	[5]
Taxol + SCH 727965	DCD02A3	SCH 727965	Glioma (Cell Line: SF-295)	[5]
Taxol + SCH 727965	DCYKUK5	SCH 727965	Glioma (Cell Line: SF-539)	[5]
Taxol + SCH 727965	DCKU2O8	SCH 727965	Papillary renal cell carcinoma (Cell Line: ACHN)	[5]
Taxol + SCH 727965	DC3X79A	SCH 727965	Plasma cell myeloma (Cell Line: RPMI-8226)	[5]
Taxol + Docetaxel	DC5HIC8	Docetaxel	Astrocytoma (Cell Line: U251)	[5]
Taxol + MK-5108	DCBWEPY	MK-5108	Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)	[5]
Taxol + Bendamustine hydrochloride	DCDMGYV	Bendamustine hydrochloride	Glioma (Cell Line: SF-295)	[5]
Taxol + Mitomycin	DCLMAVJ	Mitomycin	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[5]
Taxol + Mitomycin	DC6NW7G	Mitomycin	Papillary renal cell carcinoma (Cell Line: ACHN)	[5]
Taxol + Ridaforolimus	DCY50IV	Ridaforolimus	Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)	[5]
Taxol + MK-4827	DCZKYOP	MK-4827	Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)	[5]
Taxol + Idarubicin	DCGI7LS	Idarubicin	Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)	[5]
Taxol + Idarubicin	DC87NUD	Idarubicin	Glioblastoma? (Cell Line: T98G)	[5]
Taxol + Bleomycin	DCBJG0Z	Bleomycin	Astrocytoma (Cell Line: U251)	[5]
Taxol + Bleomycin	DCJ1UTX	Bleomycin	Astrocytoma (Cell Line: SNB-19)	[5]
Taxol + Bleomycin	DCBGIS3	Bleomycin	Glioma (Cell Line: SF-539)	[5]
Taxol + Bortezomib	DC7SL8S	Bortezomib	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[5]
Taxol + Bortezomib	DCE44FL	Bortezomib	Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)	[5]
Taxol + Bortezomib	DC0DK6F	Bortezomib	Glioma (Cell Line: SF-539)	[5]
Taxol + Valrubicin	DCX25X5	Valrubicin	Clear cell renal cell carcinoma (Cell Line: 786-0)	[5]
Taxol + Valrubicin	DCRGN3L	Valrubicin	Renal cell carcinoma (Cell Line: SN12C)	[5]
Taxol + Valrubicin	DCZ9XZY	Valrubicin	Renal cell carcinoma (Cell Line: UO-31)	[5]
Taxol + Chlorambucil	DC3DISG	Chlorambucil	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[5]
Taxol + Sorafenib	DC9T1GO	Sorafenib	Anaplastic large cell lymphoma (Cell Line: SR)	[5]
Taxol + Sorafenib	DCH8VPM	Sorafenib	Astrocytoma (Cell Line: SNB-19)	[5]
Taxol + Sorafenib	DCE5I64	Sorafenib	Clear cell renal cell carcinoma (Cell Line: 786-0)	[5]
Taxol + Sorafenib	DCIGAFZ	Sorafenib	Clear cell renal cell carcinoma (Cell Line: TK-10)	[5]
Taxol + Sorafenib	DC53KDW	Sorafenib	Clear cell renal cell carcinoma (Cell Line: A498)	[5]
Taxol + Sorafenib	DCEIQCH	Sorafenib	Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)	[5]
Taxol + ER819762	DCDH3PT	ER819762	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[5]
Taxol + ER819762	DCS3FJZ	ER819762	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[5]
Taxol + ER819762	DCF24Y5	ER819762	Chronic myelogenous leukemia (Cell Line: K-562)	[5]
Taxol + Pomalidomide	DC29MCU	Pomalidomide	Clear cell renal cell carcinoma (Cell Line: TK-10)	[5]
Taxol + Vinflunine	DC02A62	Vinflunine	Chronic myelogenous leukemia (Cell Line: K-562)	[5]
Taxol + Mepacrine	DCHL2IA	Mepacrine	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[5]
Taxol + Elacridar	DC3TDIT	Elacridar	Human papillomavirus-related cervical adenocarcinoma (Cell Line: KB-ChR-8-5-11)	[5]
Taxol + FORMESTANE	DCI9681	FORMESTANE	Plasma cell myeloma (Cell Line: RPMI-8226)	[5]
Taxol + Ibrutinib	DC2O7Y9	Ibrutinib	Diffuse large B cell lymphoma (Cell Line: TMD8)	[5]
Taxol + Dasatinib	DCZEDLK	Dasatinib	Adenocarcinoma (Cell Line: COLO320DM)	[5]
Taxol + Dasatinib	DC37VKQ	Dasatinib	Adenocarcinoma (Cell Line: DLD1)	[5]
Taxol + Dasatinib	DCZTZN8	Dasatinib	Adenocarcinoma (Cell Line: HT29)	[5]
Taxol + Dasatinib	DC4F3FE	Dasatinib	Astrocytoma (Cell Line: U251)	[5]
Taxol + Dasatinib	DCESKQH	Dasatinib	Clear cell renal cell carcinoma (Cell Line: TK-10)	[5]
Taxol + Dasatinib	DCILOAD	Dasatinib	Plasma cell myeloma (Cell Line: RPMI-8226)	[5]
Taxol + PD-0325901	DC7H8SQ	PD-0325901	Breast and ovarian cancer syndrome (Cell Line: UWB1289)	[6]
Taxol + PD-0325901	DC8TCXZ	PD-0325901	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[6]
Taxol + PD-0325901	DCSZTH2	PD-0325901	Breast carcinoma (Cell Line: ZR751)	[6]
Taxol + PD-0325901	DCVU9VW	PD-0325901	Breast carcinoma (Cell Line: OCUBM)	[6]
Taxol + PD-0325901	DCZIBKS	PD-0325901	Carcinoma (Cell Line: OV90)	[6]
Taxol + PD-0325901	DCVGPO1	PD-0325901	Carcinoma (Cell Line: EFM192B)	[6]
Taxol + PD-0325901	DC3QYU9	PD-0325901	Carcinoma (Cell Line: MDAMB436)	[6]
Taxol + PD-0325901	DCX4YRG	PD-0325901	Colon adenocarcinoma (Cell Line: LOVO)	[6]
Taxol + PD-0325901	DCL4NAN	PD-0325901	Colon carcinoma (Cell Line: RKO)	[6]
Taxol + PD-0325901	DCY0X4L	PD-0325901	Rectal adenocarcinoma (Cell Line: SW837)	[6]
Taxol + Ixabepilone	DC87P8P	Ixabepilone	Colon adenocarcinoma (Cell Line: COLO 205)	[6]
Taxol + Ixabepilone	DCA2G0N	Ixabepilone	Colon carcinoma (Cell Line: KM12)	[6]
Taxol + Ixabepilone	DC5U5XG	Ixabepilone	Invasive ductal carcinoma (Cell Line: T-47D)	[6]
Taxol + Lapatinib	DC2SZTT	Lapatinib	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[6]
Taxol + Lapatinib	DC4BBTZ	Lapatinib	Breast and ovarian cancer syndrome (Cell Line: UWB1289)	[6]
Taxol + Lapatinib	DCXHDLC	Lapatinib	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[6]
Taxol + Lapatinib	DCDKRWE	Lapatinib	Breast carcinoma (Cell Line: OCUBM)	[6]
Taxol + Lapatinib	DCBU22M	Lapatinib	Carcinoma (Cell Line: MDAMB436)	[6]
Taxol + Lapatinib	DCSARDK	Lapatinib	Carcinoma (Cell Line: MCF7)	[6]
Taxol + Lapatinib	DCVPTT3	Lapatinib	Colon adenocarcinoma (Cell Line: LOVO)	[6]
Taxol + Lapatinib	DCRYGIP	Lapatinib	Colon carcinoma (Cell Line: KM12)	[6]
Taxol + Lapatinib	DCNNDOA	Lapatinib	Invasive ductal carcinoma (Cell Line: T-47D)	[6]
Taxol + Lapatinib	DCN7F6I	Lapatinib	Rectal adenocarcinoma (Cell Line: SW837)	[6]
Taxol + PMID28460551-Compound-2	DCSMPA8	PMID28460551-Compound-2	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[6]
Taxol + PMID28460551-Compound-2	DCDJ3X0	PMID28460551-Compound-2	Breast carcinoma (Cell Line: OCUBM)	[6]
Taxol + PMID28460551-Compound-2	DC4JH6Y	PMID28460551-Compound-2	Carcinoma (Cell Line: OV90)	[6]
Taxol + PMID28460551-Compound-2	DCXR6S9	PMID28460551-Compound-2	Carcinoma (Cell Line: EFM192B)	[6]
Taxol + PMID28460551-Compound-2	DCFDMBU	PMID28460551-Compound-2	Carcinoma (Cell Line: MDAMB436)	[6]
Taxol + PMID28460551-Compound-2	DCHLYER	PMID28460551-Compound-2	Colon adenocarcinoma (Cell Line: LOVO)	[6]
Taxol + PMID28460551-Compound-2	DCOL3P4	PMID28460551-Compound-2	Colon carcinoma (Cell Line: RKO)	[6]
Taxol + PMID28460551-Compound-2	DC69HGD	PMID28460551-Compound-2	Invasive ductal carcinoma (Cell Line: T-47D)	[6]
Taxol + PMID28460551-Compound-2	DCCS71X	PMID28460551-Compound-2	Rectal adenocarcinoma (Cell Line: SW837)	[6]
Taxol + Arsenic trioxide	DCLNK5Y	Arsenic trioxide	Invasive ductal carcinoma (Cell Line: T-47D)	[6]
Taxol + RTB101	DC0T5VG	RTB101	Breast carcinoma (Cell Line: OCUBM)	[6]
Taxol + RTB101	DC3CIWF	RTB101	Colon carcinoma (Cell Line: RKO)	[6]
Taxol + RTB101	DCDNK38	RTB101	Invasive ductal carcinoma (Cell Line: T-47D)	[6]
Taxol + RTB101	DCTRQ30	RTB101	Rectal adenocarcinoma (Cell Line: SW837)	[6]
Taxol + Plicamycin	DC1ZGE9	Plicamycin	Carcinoma (Cell Line: RXF 393)	[6]
Taxol + Plicamycin	DCU7MOJ	Plicamycin	Carcinoma (Cell Line: MCF7)	[6]
Taxol + Plicamycin	DCRFWH0	Plicamycin	Colon carcinoma (Cell Line: KM12)	[6]
Taxol + Plicamycin	DC3ONFM	Plicamycin	Invasive ductal carcinoma (Cell Line: BT-549)	[6]
Taxol + Plicamycin	DCUZACQ	Plicamycin	Invasive ductal carcinoma (Cell Line: HS 578T)	[6]
Taxol + Triapine	DCS5AQF	Triapine	Colon adenocarcinoma (Cell Line: COLO 205)	[6]
Taxol + SNX-2112	DCNZ06C	SNX-2112	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[6]
Taxol + SNX-2112	DCG6GFK	SNX-2112	Breast carcinoma (Cell Line: OCUBM)	[6]
Taxol + SNX-2112	DCF49E1	SNX-2112	Carcinoma (Cell Line: OV90)	[6]
Taxol + SNX-2112	DCS4BSH	SNX-2112	Carcinoma (Cell Line: MDAMB436)	[6]
Taxol + SNX-2112	DC9L7NX	SNX-2112	Colon adenocarcinoma (Cell Line: LOVO)	[6]
Taxol + SNX-2112	DCRIXV0	SNX-2112	Colon carcinoma (Cell Line: RKO)	[6]
Taxol + SNX-2112	DCQZ3RL	SNX-2112	Rectal adenocarcinoma (Cell Line: SW837)	[6]
Taxol + Terameprocol	DCXUVF3	Terameprocol	Colon carcinoma (Cell Line: KM12)	[6]
Taxol + SCH 727965	DCX9VG3	SCH 727965	Colon carcinoma (Cell Line: KM12)	[6]
Taxol + SCH 727965	DCBVHW3	SCH 727965	Invasive ductal carcinoma (Cell Line: HS 578T)	[6]
Taxol + SCH 727965	DCTF34Y	SCH 727965	Rectal adenocarcinoma (Cell Line: SW837)	[6]
Taxol + Erlotinib	DCX0DJT	Erlotinib	Breast carcinoma (Cell Line: OCUBM)	[6]
Taxol + Erlotinib	DCRGN7E	Erlotinib	Carcinoma (Cell Line: EFM192B)	[6]
Taxol + Docetaxel	DCJ3IQ2	Docetaxel	Colon adenocarcinoma (Cell Line: COLO 205)	[6]
Taxol + MK-5108	DCY402E	MK-5108	Breast and ovarian cancer syndrome (Cell Line: UWB1289)	[6]
Taxol + MK-5108	DC7Z562	MK-5108	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[6]
Taxol + MK-5108	DCU9KRX	MK-5108	Breast carcinoma (Cell Line: OCUBM)	[6]
Taxol + MK-5108	DCNS58T	MK-5108	Carcinoma (Cell Line: EFM192B)	[6]
Taxol + MK-5108	DCLFAOP	MK-5108	Carcinoma (Cell Line: MDAMB436)	[6]
Taxol + MK-5108	DCNN52G	MK-5108	Colon adenocarcinoma (Cell Line: LOVO)	[6]
Taxol + MK-5108	DCEJTCT	MK-5108	Invasive ductal carcinoma (Cell Line: T-47D)	[6]
Taxol + Ridaforolimus	DCXI2FY	Ridaforolimus	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[6]
Taxol + Ridaforolimus	DCP02CS	Ridaforolimus	Carcinoma (Cell Line: OV90)	[6]
Taxol + Ridaforolimus	DC54L7L	Ridaforolimus	Carcinoma (Cell Line: EFM192B)	[6]
Taxol + Ridaforolimus	DCSWG7D	Ridaforolimus	Carcinoma (Cell Line: MDAMB436)	[6]
Taxol + Ridaforolimus	DCTHKEL	Ridaforolimus	Colon carcinoma (Cell Line: RKO)	[6]
Taxol + Ridaforolimus	DC6ICEC	Ridaforolimus	Rectal adenocarcinoma (Cell Line: SW837)	[6]
Taxol + MK-4827	DCWCOXW	MK-4827	Breast and ovarian cancer syndrome (Cell Line: UWB1289)	[6]
Taxol + MK-4827	DC87280	MK-4827	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[6]
Taxol + MK-4827	DCLGQ69	MK-4827	Breast carcinoma (Cell Line: KPL1)	[6]
Taxol + MK-4827	DCDQW9D	MK-4827	Breast carcinoma (Cell Line: OCUBM)	[6]
Taxol + MK-4827	DCI4NAJ	MK-4827	Carcinoma (Cell Line: OV90)	[6]
Taxol + MK-4827	DC7OV6C	MK-4827	Carcinoma (Cell Line: EFM192B)	[6]
Taxol + MK-4827	DCDF9YY	MK-4827	Colon adenocarcinoma (Cell Line: LOVO)	[6]
Taxol + MK-4827	DCXTNRG	MK-4827	Colon carcinoma (Cell Line: RKO)	[6]
Taxol + MK-4827	DCYMBDC	MK-4827	Invasive ductal carcinoma (Cell Line: T-47D)	[6]
Taxol + MK-4827	DCKBMZY	MK-4827	Rectal adenocarcinoma (Cell Line: SW837)	[6]
Taxol + Idarubicin	DCLTNYH	Idarubicin	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[6]
Taxol + Bleomycin	DC7Q0GR	Bleomycin	Invasive ductal carcinoma (Cell Line: T-47D)	[6]
Taxol + Bleomycin	DCC1FD2	Bleomycin	Invasive ductal carcinoma (Cell Line: HS 578T)	[6]
Taxol + Bortezomib	DCCEEJG	Bortezomib	Breast and ovarian cancer syndrome (Cell Line: UWB1289)	[6]
Taxol + Bortezomib	DCSRTH4	Bortezomib	Invasive ductal carcinoma (Cell Line: T-47D)	[6]
Taxol + Bortezomib	DCUKIE6	Bortezomib	Rectal adenocarcinoma (Cell Line: SW837)	[6]
Taxol + Valrubicin	DCL0P2X	Valrubicin	Carcinoma (Cell Line: MCF7)	[6]
Taxol + GSK525762	DCCEC9C	GSK525762	Breast and ovarian cancer syndrome (Cell Line: UWB1289)	[6]
Taxol + GSK525762	DC9T5VT	GSK525762	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[6]
Taxol + GSK525762	DC7I2LZ	GSK525762	Breast carcinoma (Cell Line: OCUBM)	[6]
Taxol + GSK525762	DCM6X3U	GSK525762	Carcinoma (Cell Line: MDAMB436)	[6]
Taxol + Cisplatin	DC45XD8	Cisplatin	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[6]
Taxol + Chlorambucil	DC54FI1	Chlorambucil	Colon adenocarcinoma (Cell Line: COLO 205)	[6]
Taxol + Sorafenib	DCPZ4TH	Sorafenib	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[6]
Taxol + Sorafenib	DC37TC3	Sorafenib	Breast carcinoma (Cell Line: ZR751)	[6]
Taxol + Sorafenib	DCHILCM	Sorafenib	Carcinoma (Cell Line: OV90)	[6]
Taxol + Sorafenib	DCQMHOP	Sorafenib	Carcinoma (Cell Line: RXF 393)	[6]
Taxol + Sorafenib	DCPF3VB	Sorafenib	Carcinoma (Cell Line: MCF7)	[6]
Taxol + Sorafenib	DCXZ0S6	Sorafenib	Colon carcinoma (Cell Line: RKO)	[6]
Taxol + Sorafenib	DCL5P58	Sorafenib	Colon carcinoma (Cell Line: KM12)	[6]
Taxol + Sorafenib	DC3JA3H	Sorafenib	Invasive ductal carcinoma (Cell Line: T-47D)	[6]
Taxol + Sorafenib	DC69G57	Sorafenib	Invasive ductal carcinoma (Cell Line: BT-549)	[6]
Taxol + ER819762	DCLZ4SC	ER819762	Invasive ductal carcinoma (Cell Line: T-47D)	[6]
Taxol + MK-2206	DCFWXTH	MK-2206	Breast and ovarian cancer syndrome (Cell Line: UWB1289)	[6]
Taxol + MK-2206	DCPCV4D	MK-2206	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[6]
Taxol + MK-2206	DCB62J1	MK-2206	Breast carcinoma (Cell Line: OCUBM)	[6]
Taxol + MK-2206	DC3R9FT	MK-2206	Carcinoma (Cell Line: EFM192B)	[6]
Taxol + MK-2206	DCOD2BL	MK-2206	Carcinoma (Cell Line: MDAMB436)	[6]
Taxol + MK-2206	DC64ZXE	MK-2206	Colon carcinoma (Cell Line: RKO)	[6]
Taxol + Pomalidomide	DC6KFW5	Pomalidomide	Colon adenocarcinoma (Cell Line: COLO 205)	[6]
Taxol + Vinflunine	DC70TZC	Vinflunine	Invasive ductal carcinoma (Cell Line: BT-549)	[6]
Taxol + Dasatinib	DCLDGY4	Dasatinib	Breast carcinoma (Cell Line: ZR751)	[6]
Taxol + Dasatinib	DCA3ZY0	Dasatinib	Breast carcinoma (Cell Line: OCUBM)	[6]
Taxol + Dasatinib	DCD6RC8	Dasatinib	Carcinoma (Cell Line: OV90)	[6]
Taxol + Dasatinib	DC79KUD	Dasatinib	Carcinoma (Cell Line: EFM192B)	[6]
Taxol + Dasatinib	DCPTMXU	Dasatinib	Carcinoma (Cell Line: MDAMB436)	[6]
Taxol + Dasatinib	DCQAFKL	Dasatinib	Colon carcinoma (Cell Line: RKO)	[6]
Taxol + Dasatinib	DCSBLR2	Dasatinib	Colon carcinoma (Cell Line: KM12)	[6]
Taxol + Dasatinib	DCGWRIZ	Dasatinib	Invasive ductal carcinoma (Cell Line: T-47D)	[6]
Taxol + Pentostatin	DC6WWTG	Pentostatin	Adenocarcinoma (Cell Line: HCT-15)	[7]
Taxol + Fulvestrant	DCZFB7O	Fulvestrant	Adenocarcinoma (Cell Line: HCC-2998)	[7]
Taxol + Fulvestrant	DCUELK7	Fulvestrant	Amelanotic melanoma (Cell Line: MDA-MB-435)	[7]
Taxol + Fulvestrant	DCRIRXM	Fulvestrant	Cutaneous melanoma (Cell Line: SK-MEL-28)	[7]
Taxol + Fulvestrant	DC13J0J	Fulvestrant	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[7]
Taxol + PD-0325901	DC2YDC0	PD-0325901	Adenocarcinoma (Cell Line: CAOV3)	[7]
Taxol + PD-0325901	DCRGWPY	PD-0325901	Adenocarcinoma (Cell Line: OVCAR3)	[7]
Taxol + PD-0325901	DCF5M8J	PD-0325901	Adenocarcinoma (Cell Line: A427)	[7]
Taxol + PD-0325901	DCRYGZ8	PD-0325901	Adenocarcinoma (Cell Line: NCIH23)	[7]
Taxol + PD-0325901	DC2M4GP	PD-0325901	Adenocarcinoma (Cell Line: NCIH520)	[7]
Taxol + PD-0325901	DCDRBWT	PD-0325901	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Taxol + PD-0325901	DC5ZR81	PD-0325901	Adenocarcinoma (Cell Line: HCT116)	[7]
Taxol + PD-0325901	DCE1B3E	PD-0325901	Adenocarcinoma (Cell Line: HT29)	[7]
Taxol + PD-0325901	DC1ZQWU	PD-0325901	Adenocarcinoma (Cell Line: SW-620)	[7]
Taxol + PD-0325901	DCPTQAX	PD-0325901	Amelanotic melanoma (Cell Line: A2058)	[7]
Taxol + PD-0325901	DCF8UGP	PD-0325901	Germ cell tumour (Cell Line: PA1)	[7]
Taxol + PD-0325901	DC5K6WQ	PD-0325901	Large cell lung carcinoma (Cell Line: NCI-H460)	[7]
Taxol + PD-0325901	DCA0AYL	PD-0325901	Malignant melanoma (Cell Line: A375)	[7]
Taxol + PD-0325901	DCEHP32	PD-0325901	Malignant melanoma (Cell Line: HT144)	[7]
Taxol + PD-0325901	DC1AEP9	PD-0325901	Malignant melanoma (Cell Line: RPMI7951)	[7]
Taxol + PD-0325901	DCH9330	PD-0325901	Malignant melanoma (Cell Line: SKMEL30)	[7]
Taxol + PD-0325901	DCTN1G3	PD-0325901	Mesothelioma (Cell Line: MSTO)	[7]
Taxol + PD-0325901	DCJSIOH	PD-0325901	Non small cell carcinoma (Cell Line: SKMES1)	[7]
Taxol + PD-0325901	DCD2HJL	PD-0325901	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Taxol + PD-0325901	DCSPW4C	PD-0325901	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Taxol + PD-0325901	DC7KBLO	PD-0325901	Prostate carcinoma (Cell Line: VCAP)	[7]
Taxol + Ixabepilone	DCGXSWR	Ixabepilone	Adenocarcinoma (Cell Line: DU-145)	[7]
Taxol + Ixabepilone	DCY6EV0	Ixabepilone	Adenocarcinoma (Cell Line: A549)	[7]
Taxol + Ixabepilone	DCR3171	Ixabepilone	Adenocarcinoma (Cell Line: SW-620)	[7]
Taxol + Ixabepilone	DC3HERI	Ixabepilone	Adenocarcinoma (Cell Line: HT29)	[7]
Taxol + Ixabepilone	DC30OND	Ixabepilone	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[7]
Taxol + Ixabepilone	DCSWR1P	Ixabepilone	Large cell lung carcinoma (Cell Line: NCI-H460)	[7]
Taxol + Ixabepilone	DCXL5MF	Ixabepilone	Lung adenocarcinoma (Cell Line: NCI-H522)	[7]
Taxol + Ixabepilone	DC5AT0U	Ixabepilone	Malignant melanoma (Cell Line: UACC62)	[7]
Taxol + Ixabepilone	DC33HGQ	Ixabepilone	Prostate carcinoma (Cell Line: PC-3)	[7]
Taxol + Dactinomycin	DC386GQ	Dactinomycin	Adenocarcinoma (Cell Line: DU-145)	[7]
Taxol + Lapatinib	DCK6Z93	Lapatinib	Adenocarcinoma (Cell Line: DU-145)	[7]
Taxol + Lapatinib	DC7WQGF	Lapatinib	Adenocarcinoma (Cell Line: CAOV3)	[7]
Taxol + Lapatinib	DCYHE5D	Lapatinib	Adenocarcinoma (Cell Line: OVCAR3)	[7]
Taxol + Lapatinib	DCT36VT	Lapatinib	Adenocarcinoma (Cell Line: A549)	[7]
Taxol + Lapatinib	DC61E9U	Lapatinib	Adenocarcinoma (Cell Line: NCIH23)	[7]
Taxol + Lapatinib	DCL01S3	Lapatinib	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Taxol + Lapatinib	DCN27YH	Lapatinib	Adenocarcinoma (Cell Line: DLD1)	[7]
Taxol + Lapatinib	DC3HLC1	Lapatinib	Amelanotic melanoma (Cell Line: A2058)	[7]
Taxol + Lapatinib	DCEC35A	Lapatinib	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[7]
Taxol + Lapatinib	DCPYKCL	Lapatinib	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)	[7]
Taxol + Lapatinib	DCJI5XI	Lapatinib	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[7]
Taxol + Lapatinib	DCO2RJ6	Lapatinib	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[7]
Taxol + Lapatinib	DCKOL9M	Lapatinib	Lung adenocarcinoma (Cell Line: EKVX)	[7]
Taxol + Lapatinib	DCXSRCN	Lapatinib	Lung adenocarcinoma (Cell Line: HOP-62)	[7]
Taxol + Lapatinib	DC034D1	Lapatinib	Lung adenocarcinoma (Cell Line: NCI-H522)	[7]
Taxol + Lapatinib	DCYD78S	Lapatinib	Malignant melanoma (Cell Line: HT144)	[7]
Taxol + Lapatinib	DCDAM0L	Lapatinib	Malignant melanoma (Cell Line: RPMI7951)	[7]
Taxol + Lapatinib	DCGWUSA	Lapatinib	Malignant melanoma (Cell Line: SKMEL30)	[7]
Taxol + Lapatinib	DCJ75O1	Lapatinib	Malignant melanoma (Cell Line: UACC62)	[7]
Taxol + Lapatinib	DCU9IPI	Lapatinib	Melanoma (Cell Line: UACC-257)	[7]
Taxol + Lapatinib	DCUNO9J	Lapatinib	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[7]
Taxol + Lapatinib	DCGP6NU	Lapatinib	Non small cell carcinoma (Cell Line: SKMES1)	[7]
Taxol + Lapatinib	DCPRU66	Lapatinib	Non-small cell lung carcinoma (Cell Line: HOP-92)	[7]
Taxol + Lapatinib	DCI4O4J	Lapatinib	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Taxol + Lapatinib	DCL5X5I	Lapatinib	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Taxol + Lapatinib	DCD8P7I	Lapatinib	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[7]
Taxol + Lapatinib	DCFIFV7	Lapatinib	Prostate carcinoma (Cell Line: PC-3)	[7]
Taxol + MK-1775	DC6H2ID	MK-1775	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Taxol + MK-1775	DC3K8EN	MK-1775	Germ cell tumour (Cell Line: PA1)	[7]
Taxol + MK-1775	DCGYJZA	MK-1775	Malignant melanoma (Cell Line: RPMI7951)	[7]
Taxol + MK-1775	DCD58VV	MK-1775	Malignant melanoma (Cell Line: A375)	[7]
Taxol + MK-1775	DCKR90C	MK-1775	Mesothelioma (Cell Line: MSTO)	[7]
Taxol + MK-1775	DCWQJ5C	MK-1775	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Taxol + PMID28460551-Compound-2	DC7NET9	PMID28460551-Compound-2	Adenocarcinoma (Cell Line: OVCAR3)	[7]
Taxol + PMID28460551-Compound-2	DCFA8VH	PMID28460551-Compound-2	Adenocarcinoma (Cell Line: NCIH1650)	[7]
Taxol + PMID28460551-Compound-2	DCZ51LI	PMID28460551-Compound-2	Adenocarcinoma (Cell Line: NCIH2122)	[7]
Taxol + PMID28460551-Compound-2	DCDDWM7	PMID28460551-Compound-2	Adenocarcinoma (Cell Line: NCIH520)	[7]
Taxol + PMID28460551-Compound-2	DC8E89A	PMID28460551-Compound-2	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Taxol + PMID28460551-Compound-2	DCQBZ1R	PMID28460551-Compound-2	Adenocarcinoma (Cell Line: DLD1)	[7]
Taxol + PMID28460551-Compound-2	DCZT409	PMID28460551-Compound-2	Adenocarcinoma (Cell Line: HCT116)	[7]
Taxol + PMID28460551-Compound-2	DCIWYIJ	PMID28460551-Compound-2	Adenocarcinoma (Cell Line: HT29)	[7]
Taxol + PMID28460551-Compound-2	DCOUQ43	PMID28460551-Compound-2	Adenocarcinoma (Cell Line: SW-620)	[7]
Taxol + PMID28460551-Compound-2	DCAMPXH	PMID28460551-Compound-2	Amelanotic melanoma (Cell Line: MDA-MB-435)	[7]
Taxol + PMID28460551-Compound-2	DCUBTG4	PMID28460551-Compound-2	Germ cell tumour (Cell Line: PA1)	[7]
Taxol + PMID28460551-Compound-2	DCPTIN7	PMID28460551-Compound-2	Large cell lung carcinoma (Cell Line: NCI-H460)	[7]
Taxol + PMID28460551-Compound-2	DCUSRY2	PMID28460551-Compound-2	Malignant melanoma (Cell Line: A375)	[7]
Taxol + PMID28460551-Compound-2	DCVLAIR	PMID28460551-Compound-2	Malignant melanoma (Cell Line: HT144)	[7]
Taxol + PMID28460551-Compound-2	DCGB5BW	PMID28460551-Compound-2	Malignant melanoma (Cell Line: RPMI7951)	[7]
Taxol + PMID28460551-Compound-2	DC4ONIJ	PMID28460551-Compound-2	Malignant melanoma (Cell Line: SKMEL30)	[7]
Taxol + PMID28460551-Compound-2	DCY28QW	PMID28460551-Compound-2	Malignant melanoma (Cell Line: UACC62)	[7]
Taxol + PMID28460551-Compound-2	DCVWL9B	PMID28460551-Compound-2	Mesothelioma (Cell Line: MSTO)	[7]
Taxol + PMID28460551-Compound-2	DCIDRVJ	PMID28460551-Compound-2	Non small cell carcinoma (Cell Line: SKMES1)	[7]
Taxol + PMID28460551-Compound-2	DCE8OUP	PMID28460551-Compound-2	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Taxol + PMID28460551-Compound-2	DCLQGG9	PMID28460551-Compound-2	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Taxol + PMID28460551-Compound-2	DCAU2F9	PMID28460551-Compound-2	Prostate carcinoma (Cell Line: LNCAP)	[7]
Taxol + PMID28460551-Compound-2	DCEXR1W	PMID28460551-Compound-2	Prostate carcinoma (Cell Line: VCAP)	[7]
Taxol + Cyclophosphamide	DCGM1DV	Cyclophosphamide	Adenocarcinoma (Cell Line: HCT-15)	[7]
Taxol + Arsenic trioxide	DCLDH3Z	Arsenic trioxide	Adenocarcinoma (Cell Line: A549)	[7]
Taxol + Arsenic trioxide	DCC8CB0	Arsenic trioxide	Large cell lung carcinoma (Cell Line: NCI-H460)	[7]
Taxol + Arsenic trioxide	DCJMDWK	Arsenic trioxide	Lung adenocarcinoma (Cell Line: HOP-62)	[7]
Taxol + Arsenic trioxide	DCP0W50	Arsenic trioxide	Malignant melanoma (Cell Line: LOX IMVI)	[7]
Taxol + Arsenic trioxide	DCEBIK2	Arsenic trioxide	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[7]
Taxol + RTB101	DCS7NMJ	RTB101	Adenocarcinoma (Cell Line: NCIH520)	[7]
Taxol + RTB101	DC92RGN	RTB101	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Taxol + RTB101	DCZV5KI	RTB101	Adenocarcinoma (Cell Line: DLD1)	[7]
Taxol + RTB101	DCGRRQS	RTB101	Adenocarcinoma (Cell Line: SW-620)	[7]
Taxol + RTB101	DCBBQ4W	RTB101	Amelanotic melanoma (Cell Line: A2058)	[7]
Taxol + RTB101	DCTTLOL	RTB101	Germ cell tumour (Cell Line: PA1)	[7]
Taxol + RTB101	DCZSP5I	RTB101	Large cell lung carcinoma (Cell Line: NCI-H460)	[7]
Taxol + RTB101	DCZNR2C	RTB101	Malignant melanoma (Cell Line: A375)	[7]
Taxol + RTB101	DCH19U1	RTB101	Malignant melanoma (Cell Line: HT144)	[7]
Taxol + RTB101	DCZ9I0Z	RTB101	Malignant melanoma (Cell Line: RPMI7951)	[7]
Taxol + RTB101	DCR11MQ	RTB101	Malignant melanoma (Cell Line: SKMEL30)	[7]
Taxol + RTB101	DCFL9U6	RTB101	Mesothelioma (Cell Line: MSTO)	[7]
Taxol + RTB101	DCFKD6E	RTB101	Non small cell carcinoma (Cell Line: SKMES1)	[7]
Taxol + RTB101	DCB4T7D	RTB101	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Taxol + RTB101	DC2GCV1	RTB101	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Taxol + SCH-900776	DCAHCR1	SCH-900776	Adenocarcinoma (Cell Line: OVCAR3)	[7]
Taxol + SCH-900776	DCQ1CLF	SCH-900776	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Taxol + SCH-900776	DCKA3X6	SCH-900776	Malignant melanoma (Cell Line: A375)	[7]
Taxol + SCH-900776	DC5I0N9	SCH-900776	Malignant melanoma (Cell Line: RPMI7951)	[7]
Taxol + SCH-900776	DCBS0X9	SCH-900776	Mesothelioma (Cell Line: MSTO)	[7]
Taxol + SCH-900776	DCNQDIF	SCH-900776	Non small cell carcinoma (Cell Line: SKMES1)	[7]
Taxol + SCH-900776	DCQD7SS	SCH-900776	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Taxol + SCH-900776	DC57ZNT	SCH-900776	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Taxol + Plicamycin	DC7VPE0	Plicamycin	Adenocarcinoma (Cell Line: DU-145)	[7]
Taxol + Plicamycin	DC86HIN	Plicamycin	Adenocarcinoma (Cell Line: A549)	[7]
Taxol + Plicamycin	DCLNKO8	Plicamycin	Adenocarcinoma (Cell Line: HCT116)	[7]
Taxol + Plicamycin	DCAGCHC	Plicamycin	Adenocarcinoma (Cell Line: SW-620)	[7]
Taxol + Plicamycin	DCX8VYZ	Plicamycin	Adenocarcinoma (Cell Line: HCC-2998)	[7]
Taxol + Plicamycin	DCV8S3U	Plicamycin	Amelanotic melanoma (Cell Line: MDA-MB-435)	[7]
Taxol + Plicamycin	DCJ1IHX	Plicamycin	Cutaneous melanoma (Cell Line: SK-MEL-28)	[7]
Taxol + Plicamycin	DCEAN0G	Plicamycin	Cutaneous melanoma (Cell Line: SK-MEL-5)	[7]
Taxol + Plicamycin	DC9SA5G	Plicamycin	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[7]
Taxol + Plicamycin	DCT1NJN	Plicamycin	Lung adenocarcinoma (Cell Line: HOP-62)	[7]
Taxol + Plicamycin	DCMKTHX	Plicamycin	Malignant melanoma (Cell Line: LOX IMVI)	[7]
Taxol + Plicamycin	DCPCIHF	Plicamycin	Melanoma (Cell Line: UACC-257)	[7]
Taxol + Plicamycin	DC0ME06	Plicamycin	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Taxol + Plicamycin	DC7Q6KU	Plicamycin	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[7]
Taxol + Triapine	DCBYPD1	Triapine	Prostate carcinoma (Cell Line: PC-3)	[7]
Taxol + Topetecan	DCPM5VL	Topetecan	Adenocarcinoma (Cell Line: A549)	[7]
Taxol + Topetecan	DCGTBXG	Topetecan	Large cell lung carcinoma (Cell Line: NCI-H460)	[7]
Taxol + Pralatrexate	DCYRLRO	Pralatrexate	Adenocarcinoma (Cell Line: HCT116)	[7]
Taxol + Pralatrexate	DC8PA5U	Pralatrexate	Prostate carcinoma (Cell Line: PC-3)	[7]
Taxol + SNX-2112	DCO160B	SNX-2112	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Taxol + SNX-2112	DCBAQG3	SNX-2112	Adenocarcinoma (Cell Line: SW-620)	[7]
Taxol + SNX-2112	DCAKJ2B	SNX-2112	Amelanotic melanoma (Cell Line: A2058)	[7]
Taxol + SNX-2112	DCXRNYU	SNX-2112	Germ cell tumour (Cell Line: PA1)	[7]
Taxol + SNX-2112	DCWVYYX	SNX-2112	Large cell lung carcinoma (Cell Line: NCI-H460)	[7]
Taxol + SNX-2112	DC7F7VA	SNX-2112	Malignant melanoma (Cell Line: A375)	[7]
Taxol + SNX-2112	DC0QXK4	SNX-2112	Malignant melanoma (Cell Line: HT144)	[7]
Taxol + SNX-2112	DCDRR2F	SNX-2112	Malignant melanoma (Cell Line: RPMI7951)	[7]
Taxol + SNX-2112	DCJX4O1	SNX-2112	Malignant melanoma (Cell Line: SKMEL30)	[7]
Taxol + SNX-2112	DC80HQW	SNX-2112	Malignant melanoma (Cell Line: UACC62)	[7]
Taxol + SNX-2112	DCPXR49	SNX-2112	Mesothelioma (Cell Line: MSTO)	[7]
Taxol + SNX-2112	DCM1MOO	SNX-2112	Non small cell carcinoma (Cell Line: SKMES1)	[7]
Taxol + SNX-2112	DCN603S	SNX-2112	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Taxol + SNX-2112	DCKN6S7	SNX-2112	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Taxol + Terameprocol	DCLGICU	Terameprocol	Adenocarcinoma (Cell Line: SW-620)	[7]
Taxol + Terameprocol	DCLOXKP	Terameprocol	Adenocarcinoma (Cell Line: HCT-15)	[7]
Taxol + Terameprocol	DCCO45P	Terameprocol	Amelanotic melanoma (Cell Line: M14)	[7]
Taxol + Terameprocol	DCJ0S70	Terameprocol	Non-small cell lung carcinoma (Cell Line: HOP-92)	[7]
Taxol + SCH 727965	DCRX4P6	SCH 727965	Adenocarcinoma (Cell Line: CAOV3)	[7]
Taxol + SCH 727965	DC179M2	SCH 727965	Adenocarcinoma (Cell Line: A427)	[7]
Taxol + SCH 727965	DC7V25M	SCH 727965	Adenocarcinoma (Cell Line: NCIH520)	[7]
Taxol + SCH 727965	DC0QVLQ	SCH 727965	Adenocarcinoma (Cell Line: NCIH23)	[7]
Taxol + SCH 727965	DCYJW5I	SCH 727965	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Taxol + SCH 727965	DCYJXV5	SCH 727965	Adenocarcinoma (Cell Line: HCT116)	[7]
Taxol + SCH 727965	DC3W6XM	SCH 727965	Adenocarcinoma (Cell Line: HT29)	[7]
Taxol + SCH 727965	DC896L4	SCH 727965	Adenocarcinoma (Cell Line: SW-620)	[7]
Taxol + SCH 727965	DCS1NLX	SCH 727965	Amelanotic melanoma (Cell Line: A2058)	[7]
Taxol + SCH 727965	DC96IE4	SCH 727965	Amelanotic melanoma (Cell Line: M14)	[7]
Taxol + SCH 727965	DCIIFVL	SCH 727965	Cutaneous melanoma (Cell Line: SK-MEL-5)	[7]
Taxol + SCH 727965	DCY64R5	SCH 727965	Germ cell tumour (Cell Line: PA1)	[7]
Taxol + SCH 727965	DC5M15X	SCH 727965	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[7]
Taxol + SCH 727965	DCO0H3K	SCH 727965	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[7]
Taxol + SCH 727965	DCOOBWK	SCH 727965	Malignant melanoma (Cell Line: A375)	[7]
Taxol + SCH 727965	DCOC51Q	SCH 727965	Malignant melanoma (Cell Line: UACC62)	[7]
Taxol + SCH 727965	DCPXMIP	SCH 727965	Malignant melanoma (Cell Line: LOX IMVI)	[7]
Taxol + SCH 727965	DC4IGH4	SCH 727965	Mesothelioma (Cell Line: MSTO)	[7]
Taxol + SCH 727965	DC7G4M2	SCH 727965	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[7]
Taxol + SCH 727965	DCELY2Y	SCH 727965	Non small cell carcinoma (Cell Line: SKMES1)	[7]
Taxol + SCH 727965	DCVKKNJ	SCH 727965	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Taxol + SCH 727965	DCXD9BX	SCH 727965	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Taxol + Erlotinib	DC9LWZ4	Erlotinib	Adenocarcinoma (Cell Line: CAOV3)	[7]
Taxol + Erlotinib	DCJE5QM	Erlotinib	Adenocarcinoma (Cell Line: OVCAR3)	[7]
Taxol + Erlotinib	DCH27YA	Erlotinib	Adenocarcinoma (Cell Line: NCIH2122)	[7]
Taxol + Erlotinib	DC5VT3P	Erlotinib	Adenocarcinoma (Cell Line: NCIH520)	[7]
Taxol + Erlotinib	DCCVPFR	Erlotinib	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Taxol + Erlotinib	DCIH7G3	Erlotinib	Adenocarcinoma (Cell Line: DLD1)	[7]
Taxol + Erlotinib	DCUDDK0	Erlotinib	Adenocarcinoma (Cell Line: HT29)	[7]
Taxol + Erlotinib	DC01B5H	Erlotinib	Adenocarcinoma (Cell Line: SW-620)	[7]
Taxol + Erlotinib	DCX8RE7	Erlotinib	Germ cell tumour (Cell Line: PA1)	[7]
Taxol + Erlotinib	DCF7ZHQ	Erlotinib	Large cell lung carcinoma (Cell Line: NCI-H460)	[7]
Taxol + Erlotinib	DCJA82X	Erlotinib	Malignant melanoma (Cell Line: A375)	[7]
Taxol + Erlotinib	DCUV740	Erlotinib	Malignant melanoma (Cell Line: HT144)	[7]
Taxol + Erlotinib	DCCK40Q	Erlotinib	Malignant melanoma (Cell Line: RPMI7951)	[7]
Taxol + Erlotinib	DCAZ60S	Erlotinib	Malignant melanoma (Cell Line: SKMEL30)	[7]
Taxol + Erlotinib	DCG0R6M	Erlotinib	Malignant melanoma (Cell Line: UACC62)	[7]
Taxol + Erlotinib	DCPWGK0	Erlotinib	Mesothelioma (Cell Line: MSTO)	[7]
Taxol + Erlotinib	DC8EXCJ	Erlotinib	Non small cell carcinoma (Cell Line: SKMES1)	[7]
Taxol + Erlotinib	DCOGBJH	Erlotinib	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Taxol + Erlotinib	DCH2AY4	Erlotinib	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Taxol + Docetaxel	DC8FT6I	Docetaxel	Adenocarcinoma (Cell Line: DU-145)	[7]
Taxol + Docetaxel	DCU1V9T	Docetaxel	Prostate carcinoma (Cell Line: PC-3)	[7]
Taxol + MK-5108	DC6EEQ1	MK-5108	Adenocarcinoma (Cell Line: CAOV3)	[7]
Taxol + MK-5108	DC0U3B1	MK-5108	Adenocarcinoma (Cell Line: A427)	[7]
Taxol + MK-5108	DCWJK29	MK-5108	Adenocarcinoma (Cell Line: NCIH1650)	[7]
Taxol + MK-5108	DC8X8MF	MK-5108	Adenocarcinoma (Cell Line: NCIH2122)	[7]
Taxol + MK-5108	DCAY37I	MK-5108	Adenocarcinoma (Cell Line: NCIH23)	[7]
Taxol + MK-5108	DCLWNDA	MK-5108	Adenocarcinoma (Cell Line: NCIH520)	[7]
Taxol + MK-5108	DCXOZI7	MK-5108	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Taxol + MK-5108	DCCX2OC	MK-5108	Adenocarcinoma (Cell Line: DLD1)	[7]
Taxol + MK-5108	DCAZ0ZG	MK-5108	Adenocarcinoma (Cell Line: SW-620)	[7]
Taxol + MK-5108	DCF7PIV	MK-5108	Amelanotic melanoma (Cell Line: A2058)	[7]
Taxol + MK-5108	DC6AI7I	MK-5108	Germ cell tumour (Cell Line: PA1)	[7]
Taxol + MK-5108	DC6KJ76	MK-5108	Large cell lung carcinoma (Cell Line: NCI-H460)	[7]
Taxol + MK-5108	DCW9M6D	MK-5108	Malignant melanoma (Cell Line: RPMI7951)	[7]
Taxol + MK-5108	DCD8CR0	MK-5108	Malignant melanoma (Cell Line: SKMEL30)	[7]
Taxol + MK-5108	DC59QWU	MK-5108	Mesothelioma (Cell Line: MSTO)	[7]
Taxol + MK-5108	DC4ZLGG	MK-5108	Non small cell carcinoma (Cell Line: SKMES1)	[7]
Taxol + MK-5108	DCU846O	MK-5108	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Taxol + MK-5108	DCG0S7C	MK-5108	Prostate carcinoma (Cell Line: VCAP)	[7]
Taxol + Mitomycin	DCWC3TT	Mitomycin	Adenocarcinoma (Cell Line: DU-145)	[7]
Taxol + Mitomycin	DCH1G4T	Mitomycin	Adenocarcinoma (Cell Line: SW-620)	[7]
Taxol + Mitomycin	DCE8EA7	Mitomycin	Adenocarcinoma (Cell Line: HCT-15)	[7]
Taxol + Mitomycin	DCX80D5	Mitomycin	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[7]
Taxol + Ridaforolimus	DCECDFA	Ridaforolimus	Adenocarcinoma (Cell Line: A427)	[7]
Taxol + Ridaforolimus	DCWKYC8	Ridaforolimus	Adenocarcinoma (Cell Line: NCIH1650)	[7]
Taxol + Ridaforolimus	DCBII65	Ridaforolimus	Adenocarcinoma (Cell Line: NCIH2122)	[7]
Taxol + Ridaforolimus	DCXXNHC	Ridaforolimus	Adenocarcinoma (Cell Line: NCIH520)	[7]
Taxol + Ridaforolimus	DCBIJMR	Ridaforolimus	Adenocarcinoma (Cell Line: DLD1)	[7]
Taxol + Ridaforolimus	DCSMZJ0	Ridaforolimus	Adenocarcinoma (Cell Line: HCT116)	[7]
Taxol + Ridaforolimus	DCTGM32	Ridaforolimus	Adenocarcinoma (Cell Line: HT29)	[7]
Taxol + Ridaforolimus	DCIUV69	Ridaforolimus	Germ cell tumour (Cell Line: PA1)	[7]
Taxol + Ridaforolimus	DC86OV8	Ridaforolimus	Large cell lung carcinoma (Cell Line: NCI-H460)	[7]
Taxol + Ridaforolimus	DCIZ5AX	Ridaforolimus	Malignant melanoma (Cell Line: A375)	[7]
Taxol + Ridaforolimus	DCDVY4I	Ridaforolimus	Malignant melanoma (Cell Line: HT144)	[7]
Taxol + Ridaforolimus	DCD8I9I	Ridaforolimus	Malignant melanoma (Cell Line: RPMI7951)	[7]
Taxol + Ridaforolimus	DCZ3QDA	Ridaforolimus	Malignant melanoma (Cell Line: UACC62)	[7]
Taxol + Ridaforolimus	DCDK86V	Ridaforolimus	Mesothelioma (Cell Line: MSTO)	[7]
Taxol + Ridaforolimus	DC4HIA9	Ridaforolimus	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Taxol + Ridaforolimus	DCAV1OH	Ridaforolimus	Prostate carcinoma (Cell Line: LNCAP)	[7]
Taxol + Ridaforolimus	DCA92X7	Ridaforolimus	Prostate carcinoma (Cell Line: VCAP)	[7]
Taxol + TEM	DCGEMV1	TEM	Adenocarcinoma (Cell Line: NCIH23)	[7]
Taxol + MK-4827	DC59LE0	MK-4827	Adenocarcinoma (Cell Line: NCIH1650)	[7]
Taxol + MK-4827	DCXKUGN	MK-4827	Adenocarcinoma (Cell Line: NCIH520)	[7]
Taxol + MK-4827	DCMOP06	MK-4827	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Taxol + MK-4827	DCCZUCO	MK-4827	Adenocarcinoma (Cell Line: DLD1)	[7]
Taxol + MK-4827	DCZ8K39	MK-4827	Adenocarcinoma (Cell Line: HT29)	[7]
Taxol + MK-4827	DCWATTV	MK-4827	Adenocarcinoma (Cell Line: SW-620)	[7]
Taxol + MK-4827	DCFVW72	MK-4827	Large cell lung carcinoma (Cell Line: NCI-H460)	[7]
Taxol + MK-4827	DCOZWBI	MK-4827	Malignant melanoma (Cell Line: HT144)	[7]
Taxol + MK-4827	DCDMG9B	MK-4827	Malignant melanoma (Cell Line: RPMI7951)	[7]
Taxol + MK-4827	DCJW27T	MK-4827	Malignant melanoma (Cell Line: SKMEL30)	[7]
Taxol + MK-4827	DCX9FK0	MK-4827	Mesothelioma (Cell Line: MSTO)	[7]
Taxol + MK-4827	DCATH9F	MK-4827	Non small cell carcinoma (Cell Line: SKMES1)	[7]
Taxol + MK-4827	DC1PCTG	MK-4827	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Taxol + MK-4827	DCT41RY	MK-4827	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Taxol + Idarubicin	DC68120	Idarubicin	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Taxol + Idarubicin	DC1JH8U	Idarubicin	Adenocarcinoma (Cell Line: SW-620)	[7]
Taxol + Idarubicin	DCWYFZ8	Idarubicin	Amelanotic melanoma (Cell Line: A2058)	[7]
Taxol + Idarubicin	DCK9YX7	Idarubicin	Large cell lung carcinoma (Cell Line: NCI-H460)	[7]
Taxol + Idarubicin	DCU40RS	Idarubicin	Malignant melanoma (Cell Line: A375)	[7]
Taxol + Idarubicin	DCHYJ17	Idarubicin	Malignant melanoma (Cell Line: RPMI7951)	[7]
Taxol + Idarubicin	DCPDAZJ	Idarubicin	Mesothelioma (Cell Line: MSTO)	[7]
Taxol + Idarubicin	DCUHPGI	Idarubicin	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Taxol + Bleomycin	DCELB7G	Bleomycin	Lung adenocarcinoma (Cell Line: EKVX)	[7]
Taxol + Bortezomib	DCSVMCC	Bortezomib	Adenocarcinoma (Cell Line: CAOV3)	[7]
Taxol + Bortezomib	DCFL4MV	Bortezomib	Adenocarcinoma (Cell Line: OVCAR3)	[7]
Taxol + Bortezomib	DCBLM1A	Bortezomib	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Taxol + Bortezomib	DCOY94A	Bortezomib	Adenocarcinoma (Cell Line: DLD1)	[7]
Taxol + Bortezomib	DCZ9NUM	Bortezomib	Adenocarcinoma (Cell Line: HCT-15)	[7]
Taxol + Bortezomib	DCT53UT	Bortezomib	Adenocarcinoma (Cell Line: HCT116)	[7]
Taxol + Bortezomib	DCAZMWN	Bortezomib	Amelanotic melanoma (Cell Line: A2058)	[7]
Taxol + Bortezomib	DCQJP5G	Bortezomib	Large cell lung carcinoma (Cell Line: NCI-H460)	[7]
Taxol + Bortezomib	DCXTBX5	Bortezomib	Malignant melanoma (Cell Line: RPMI7951)	[7]
Taxol + Bortezomib	DCRVTXY	Bortezomib	Mesothelioma (Cell Line: MSTO)	[7]
Taxol + Bortezomib	DCCI3IP	Bortezomib	Non small cell carcinoma (Cell Line: SKMES1)	[7]
Taxol + Bortezomib	DC1BZHL	Bortezomib	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Taxol + Valrubicin	DC8UHGE	Valrubicin	Amelanotic melanoma (Cell Line: MDA-MB-435)	[7]
Taxol + Valrubicin	DCQGXPE	Valrubicin	Lung adenocarcinoma (Cell Line: EKVX)	[7]
Taxol + Valrubicin	DC6PCGW	Valrubicin	Lung adenocarcinoma (Cell Line: HOP-62)	[7]
Taxol + Valrubicin	DCCJNQ5	Valrubicin	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Taxol + GSK525762	DCQVT9F	GSK525762	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Taxol + Cisplatin	DCAT885	Cisplatin	Adenocarcinoma (Cell Line: A549)	[7]
Taxol + Sorafenib	DCW62WB	Sorafenib	Adenocarcinoma (Cell Line: DU-145)	[7]
Taxol + Sorafenib	DCF6TGX	Sorafenib	Adenocarcinoma (Cell Line: CAOV3)	[7]
Taxol + Sorafenib	DCBMSK6	Sorafenib	Adenocarcinoma (Cell Line: A427)	[7]
Taxol + Sorafenib	DCV67M5	Sorafenib	Adenocarcinoma (Cell Line: NCIH520)	[7]
Taxol + Sorafenib	DCSF9CV	Sorafenib	Adenocarcinoma (Cell Line: NCIH23)	[7]
Taxol + Sorafenib	DC6LD27	Sorafenib	Adenocarcinoma (Cell Line: A549)	[7]
Taxol + Sorafenib	DCKQO5S	Sorafenib	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Taxol + Sorafenib	DCE90P1	Sorafenib	Adenocarcinoma (Cell Line: DLD1)	[7]
Taxol + Sorafenib	DCBBQ0R	Sorafenib	Adenocarcinoma (Cell Line: SW-620)	[7]
Taxol + Sorafenib	DCCEK7D	Sorafenib	Adenocarcinoma (Cell Line: HCC-2998)	[7]
Taxol + Sorafenib	DCO2XCW	Sorafenib	Adenocarcinoma (Cell Line: HCT116)	[7]
Taxol + Sorafenib	DCG1YVV	Sorafenib	Amelanotic melanoma (Cell Line: M14)	[7]
Taxol + Sorafenib	DC5CII6	Sorafenib	Cutaneous melanoma (Cell Line: SK-MEL-28)	[7]
Taxol + Sorafenib	DCGQDLR	Sorafenib	Large cell lung carcinoma (Cell Line: NCI-H460)	[7]
Taxol + Sorafenib	DC5X10G	Sorafenib	Lung adenocarcinoma (Cell Line: HOP-62)	[7]
Taxol + Sorafenib	DCQGULY	Sorafenib	Malignant melanoma (Cell Line: A375)	[7]
Taxol + Sorafenib	DCQANO2	Sorafenib	Malignant melanoma (Cell Line: HT144)	[7]
Taxol + Sorafenib	DCWRKYG	Sorafenib	Malignant melanoma (Cell Line: LOX IMVI)	[7]
Taxol + Sorafenib	DC86565	Sorafenib	Melanoma (Cell Line: SK-MEL-2)	[7]
Taxol + Sorafenib	DC0ON9S	Sorafenib	Melanoma (Cell Line: UACC-257)	[7]
Taxol + Sorafenib	DCJDXEG	Sorafenib	Mesothelioma (Cell Line: MSTO)	[7]
Taxol + Sorafenib	DCF3S7C	Sorafenib	Non small cell carcinoma (Cell Line: SKMES1)	[7]
Taxol + Sorafenib	DC2Z9B1	Sorafenib	Non-small cell lung carcinoma (Cell Line: HOP-92)	[7]
Taxol + Sorafenib	DC4YN4B	Sorafenib	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Taxol + Sorafenib	DCTD4BC	Sorafenib	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Taxol + Sorafenib	DC6VYQG	Sorafenib	Prostate carcinoma (Cell Line: VCAP)	[7]
Taxol + Sorafenib	DC0O4S5	Sorafenib	Prostate carcinoma (Cell Line: PC-3)	[7]
Taxol + ER819762	DC0WOTD	ER819762	Adenocarcinoma (Cell Line: OVCAR3)	[7]
Taxol + ER819762	DC3QI2D	ER819762	Adenocarcinoma (Cell Line: A549)	[7]
Taxol + ER819762	DCYGAN9	ER819762	Adenocarcinoma (Cell Line: HCT116)	[7]
Taxol + ER819762	DCHRBXU	ER819762	Large cell lung carcinoma (Cell Line: NCI-H460)	[7]
Taxol + ER819762	DCSKCEG	ER819762	Lung adenocarcinoma (Cell Line: HOP-62)	[7]
Taxol + ER819762	DC7N4W0	ER819762	Malignant melanoma (Cell Line: LOX IMVI)	[7]
Taxol + ER819762	DCYVHUL	ER819762	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[7]
Taxol + ER819762	DCROJ5R	ER819762	Prostate carcinoma (Cell Line: PC-3)	[7]
Taxol + MK-2206	DC73SRK	MK-2206	Adenocarcinoma (Cell Line: CAOV3)	[7]
Taxol + MK-2206	DC1P3ZJ	MK-2206	Adenocarcinoma (Cell Line: A427)	[7]
Taxol + MK-2206	DCPRNN5	MK-2206	Adenocarcinoma (Cell Line: NCIH1650)	[7]
Taxol + MK-2206	DCLZISZ	MK-2206	Adenocarcinoma (Cell Line: NCIH2122)	[7]
Taxol + MK-2206	DC60SO0	MK-2206	Adenocarcinoma (Cell Line: NCIH23)	[7]
Taxol + MK-2206	DCO9LA1	MK-2206	Adenocarcinoma (Cell Line: NCIH520)	[7]
Taxol + MK-2206	DC27003	MK-2206	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Taxol + MK-2206	DCH6DQ7	MK-2206	Adenocarcinoma (Cell Line: DLD1)	[7]
Taxol + MK-2206	DC14W6C	MK-2206	Adenocarcinoma (Cell Line: HCT116)	[7]
Taxol + MK-2206	DC7L7U5	MK-2206	Adenocarcinoma (Cell Line: HT29)	[7]
Taxol + MK-2206	DCAZM5J	MK-2206	Adenocarcinoma (Cell Line: SW-620)	[7]
Taxol + MK-2206	DCOQ454	MK-2206	Amelanotic melanoma (Cell Line: A2058)	[7]
Taxol + MK-2206	DCXUPS5	MK-2206	Germ cell tumour (Cell Line: PA1)	[7]
Taxol + MK-2206	DC8CKMN	MK-2206	Large cell lung carcinoma (Cell Line: NCI-H460)	[7]
Taxol + MK-2206	DCFZXEW	MK-2206	Malignant melanoma (Cell Line: HT144)	[7]
Taxol + MK-2206	DCU3636	MK-2206	Malignant melanoma (Cell Line: RPMI7951)	[7]
Taxol + MK-2206	DC7D1DL	MK-2206	Malignant melanoma (Cell Line: SKMEL30)	[7]
Taxol + MK-2206	DCO4U0W	MK-2206	Mesothelioma (Cell Line: MSTO)	[7]
Taxol + MK-2206	DCVF4DG	MK-2206	Non small cell carcinoma (Cell Line: SKMES1)	[7]
Taxol + MK-2206	DCH2R6J	MK-2206	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Taxol + MK-2206	DCVXZOM	MK-2206	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Taxol + MK-2206	DCX2VXT	MK-2206	Prostate carcinoma (Cell Line: VCAP)	[7]
Taxol + Pomalidomide	DCP54G9	Pomalidomide	Adenocarcinoma (Cell Line: HCT116)	[7]
Taxol + Vinflunine	DCIEOUT	Vinflunine	Adenocarcinoma (Cell Line: NCIH23)	[7]
Taxol + Vinflunine	DC8RK5R	Vinflunine	Adenocarcinoma (Cell Line: HCC-2998)	[7]
Taxol + Vinflunine	DC8JX0C	Vinflunine	Cutaneous melanoma (Cell Line: SK-MEL-28)	[7]
Taxol + Vinflunine	DCHVXR3	Vinflunine	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[7]
Taxol + Vinflunine	DCAB71M	Vinflunine	Lung adenocarcinoma (Cell Line: HOP-62)	[7]
Taxol + Vinflunine	DCRVG15	Vinflunine	Malignant melanoma (Cell Line: UACC62)	[7]
Taxol + Vinflunine	DCN5H30	Vinflunine	Malignant melanoma (Cell Line: LOX IMVI)	[7]
Taxol + Vinflunine	DCQZBRR	Vinflunine	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[7]
Taxol + Vinflunine	DCIZYXH	Vinflunine	Non-small cell lung carcinoma (Cell Line: HOP-92)	[7]
Taxol + Mepacrine	DCV75CP	Mepacrine	Amelanotic melanoma (Cell Line: MDA-MB-435)	[7]
Taxol + Mepacrine	DCNZRUM	Mepacrine	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Taxol + FORMESTANE	DCAW6FH	FORMESTANE	Adenocarcinoma (Cell Line: DU-145)	[7]
Taxol + FORMESTANE	DCSZ8W8	FORMESTANE	Adenocarcinoma (Cell Line: OVCAR3)	[7]
Taxol + FORMESTANE	DC53G4J	FORMESTANE	Adenocarcinoma (Cell Line: SW-620)	[7]
Taxol + FORMESTANE	DCWPGAQ	FORMESTANE	Melanoma (Cell Line: MALME-3M)	[7]
Taxol + FORMESTANE	DCPTPIC	FORMESTANE	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[7]
Taxol + Aminolevulinic Acid Hydrochloride	DC9EQ9Q	Aminolevulinic Acid Hydrochloride	Large cell lung carcinoma (Cell Line: NCI-H460)	[7]
Taxol + Dasatinib	DC63YAU	Dasatinib	Adenocarcinoma (Cell Line: OVCAR3)	[7]
Taxol + Dasatinib	DCZHDHY	Dasatinib	Adenocarcinoma (Cell Line: A427)	[7]
Taxol + Dasatinib	DCQZVC2	Dasatinib	Adenocarcinoma (Cell Line: NCIH520)	[7]
Taxol + Dasatinib	DCAWGUJ	Dasatinib	Germ cell tumour (Cell Line: PA1)	[7]
Taxol + Dasatinib	DCN9Z7Z	Dasatinib	Malignant melanoma (Cell Line: A375)	[7]
Taxol + Dasatinib	DCQ1RSD	Dasatinib	Malignant melanoma (Cell Line: LOX IMVI)	[7]
Taxol + Dasatinib	DCUZT9R	Dasatinib	Mesothelioma (Cell Line: MSTO)	[7]
Taxol + Dasatinib	DC50HLR	Dasatinib	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[7]
Taxol + Dasatinib	DCBMK0Y	Dasatinib	Non small cell carcinoma (Cell Line: SKMES1)	[7]
Taxol + Dasatinib	DCXLQ4B	Dasatinib	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Taxol + Dasatinib	DCREXZQ	Dasatinib	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Thioguanine + Taxol	DC0KWUB	Thioguanine	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[5]
Thioguanine + Taxol	DCC8JF4	Thioguanine	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[5]
Thioguanine + Taxol	DCWKC6K	Thioguanine	Clear cell renal cell carcinoma (Cell Line: 786-0)	[5]
Thioguanine + Taxol	DCB3D4J	Thioguanine	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[5]
Thioguanine + Taxol	DCW74HT	Thioguanine	Colon adenocarcinoma (Cell Line: COLO 205)	[6]
Thioguanine + Taxol	DCUN53M	Thioguanine	Adenocarcinoma (Cell Line: NCIH23)	[7]
Thioguanine + Taxol	DCMSTKR	Thioguanine	Non-small cell lung carcinoma (Cell Line: HOP-92)	[7]
Topotecan + Taxol	DC5LBZC	Topotecan	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[7]
Topotecan + Taxol	DC4LJ2S	Topotecan	Cutaneous melanoma (Cell Line: SK-MEL-28)	[7]
Topotecan + Taxol	DC68S58	Topotecan	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[7]
Trifluridine + Taxol	DCF8RT0	Trifluridine	Adenocarcinoma (Cell Line: HCT-15)	[7]
Trifluridine + Taxol	DCROBD9	Trifluridine	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[7]
Trifluridine + Taxol	DC6IUIG	Trifluridine	Melanoma (Cell Line: MALME-3M)	[7]
Uracil mustard + Taxol	DC24NW2	Uracil mustard	Glioma (Cell Line: SF-268)	[5]
Uracil mustard + Taxol	DCGQUQJ	Uracil mustard	Papillary renal cell carcinoma (Cell Line: ACHN)	[5]
Uracil mustard + Taxol	DCVUIOD	Uracil mustard	Plasma cell myeloma (Cell Line: RPMI-8226)	[5]
Uracil mustard + Taxol	DCJGFHW	Uracil mustard	Adenocarcinoma (Cell Line: NCIH23)	[7]
Vandetanib + Taxol	DCM02ZL	Vandetanib	Carcinoma (Cell Line: RXF 393)	[6]
Vandetanib + Taxol	DCBY7UU	Vandetanib	Adenocarcinoma (Cell Line: A549)	[7]
Vandetanib + Taxol	DC57H7P	Vandetanib	Adenocarcinoma (Cell Line: HT29)	[7]
Vandetanib + Taxol	DC0YG8M	Vandetanib	Adenocarcinoma (Cell Line: HCT-15)	[7]
Vandetanib + Taxol	DCTZQ87	Vandetanib	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[7]
Vandetanib + Taxol	DCSYUU9	Vandetanib	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[7]
Vandetanib + Taxol	DCSIMA0	Vandetanib	Glioma (Cell Line: SF-295)	[7]
Vandetanib + Taxol	DCFM3T5	Vandetanib	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[7]
Vandetanib + Taxol	DC7A7SM	Vandetanib	Lung adenocarcinoma (Cell Line: NCI-H522)	[7]
Vandetanib + Taxol	DC0A5ID	Vandetanib	Malignant melanoma (Cell Line: LOX IMVI)	[7]
Vandetanib + Taxol	DCX9SN2	Vandetanib	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[7]
Vandetanib + Taxol	DCJVN97	Vandetanib	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[7]
Vandetanib + Taxol	DC4074P	Vandetanib	Non-small cell lung carcinoma (Cell Line: HOP-92)	[7]
Vandetanib + Taxol	DCOOKA5	Vandetanib	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[7]
Vemurafenib + Taxol	DCPWE9V	Vemurafenib	Carcinoma (Cell Line: RXF 393)	[6]
Vemurafenib + Taxol	DCD1XIQ	Vemurafenib	Adenocarcinoma (Cell Line: HT29)	[7]
Vemurafenib + Taxol	DCO6T85	Vemurafenib	Amelanotic melanoma (Cell Line: MDA-MB-435)	[7]
Vemurafenib + Taxol	DCNGRG9	Vemurafenib	Chronic myelogenous leukemia (Cell Line: K-562)	[7]
Vemurafenib + Taxol	DCUVWMK	Vemurafenib	Clear cell renal cell carcinoma (Cell Line: A498)	[7]
Vemurafenib + Taxol	DCKKJOY	Vemurafenib	Clear cell renal cell carcinoma (Cell Line: 786-0)	[7]
Vemurafenib + Taxol	DCCTRHC	Vemurafenib	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[7]
Vemurafenib + Taxol	DC50C7F	Vemurafenib	Cutaneous melanoma (Cell Line: SK-MEL-5)	[7]
Vemurafenib + Taxol	DCP1H2W	Vemurafenib	Cutaneous melanoma (Cell Line: SK-MEL-28)	[7]
Vemurafenib + Taxol	DCGJ525	Vemurafenib	Glioma (Cell Line: SF-295)	[7]
Vemurafenib + Taxol	DC29LNF	Vemurafenib	Malignant melanoma (Cell Line: UACC62)	[7]
Vemurafenib + Taxol	DCQHXP7	Vemurafenib	Malignant melanoma (Cell Line: LOX IMVI)	[7]
Vemurafenib + Taxol	DC38X4Y	Vemurafenib	Melanoma (Cell Line: UACC-257)	[7]
Vemurafenib + Taxol	DCACTSF	Vemurafenib	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[7]
Vincristine + Taxol	DCHO5GA	Vincristine	Chronic myelogenous leukemia (Cell Line: K-562)	[5]
Vincristine + Taxol	DCWJ3V3	Vincristine	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[5]
Vincristine + Taxol	DC8XQFZ	Vincristine	Plasma cell myeloma (Cell Line: RPMI-8226)	[5]
Vismodegib + Taxol	DCIOAR4	Vismodegib	Carcinoma (Cell Line: RXF 393)	[6]
Vismodegib + Taxol	DCG3579	Vismodegib	Invasive ductal carcinoma (Cell Line: BT-549)	[6]
Vismodegib + Taxol	DCT1U19	Vismodegib	Invasive ductal carcinoma (Cell Line: T-47D)	[6]
Vismodegib + Taxol	DC3J5K7	Vismodegib	Adenocarcinoma (Cell Line: DU-145)	[7]
Vismodegib + Taxol	DCS85A2	Vismodegib	Adenocarcinoma (Cell Line: OVCAR3)	[7]
Vismodegib + Taxol	DCZ3JZA	Vismodegib	Adenocarcinoma (Cell Line: A549)	[7]
Vismodegib + Taxol	DCD9YXM	Vismodegib	Adenocarcinoma (Cell Line: NCIH23)	[7]
Vismodegib + Taxol	DCBWQJV	Vismodegib	Adenocarcinoma (Cell Line: HCC-2998)	[7]
Vismodegib + Taxol	DCC6WN3	Vismodegib	Adenocarcinoma (Cell Line: HT29)	[7]
Vismodegib + Taxol	DC5EE3V	Vismodegib	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[7]
Vismodegib + Taxol	DC8VG2G	Vismodegib	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[7]
Vismodegib + Taxol	DCOGTC0	Vismodegib	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[7]
Vismodegib + Taxol	DCLLGDK	Vismodegib	Clear cell renal cell carcinoma (Cell Line: A498)	[7]
Vismodegib + Taxol	DCB714H	Vismodegib	Clear cell renal cell carcinoma (Cell Line: 786-0)	[7]
Vismodegib + Taxol	DCGGFT5	Vismodegib	Glioma (Cell Line: SF-295)	[7]
Vismodegib + Taxol	DCN12PT	Vismodegib	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[7]
Vismodegib + Taxol	DC5WHS4	Vismodegib	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[7]
Vismodegib + Taxol	DCJZOYV	Vismodegib	Lung adenocarcinoma (Cell Line: NCI-H522)	[7]
Vismodegib + Taxol	DCLNUVJ	Vismodegib	Malignant melanoma (Cell Line: LOX IMVI)	[7]
Vismodegib + Taxol	DCZNP4M	Vismodegib	Malignant melanoma (Cell Line: UACC62)	[7]
Vismodegib + Taxol	DCA0GAZ	Vismodegib	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[7]
Vismodegib + Taxol	DCQYP0A	Vismodegib	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[7]
Vismodegib + Taxol	DCUAIQH	Vismodegib	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[7]
Vismodegib + Taxol	DC67CKO	Vismodegib	Prostate carcinoma (Cell Line: PC-3)	[7]
------------------------------------------------------------------------------------


⏷ Show the Full List of 917 DrugCom(s)

References

1	Paclitaxel directly binds to Bcl-2 and functionally mimics activity of Nur77. Cancer Res. 2009 Sep 1;69(17):6906-14.
2	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
3	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
4	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
5	Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
6	Biologically active neutrophil chemokine pattern in tonsillitis.Clin Exp Immunol. 2004 Mar;135(3):511-8. doi: 10.1111/j.1365-2249.2003.02390.x.
7	Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.Hum Genet. 2018 Apr;137(4):293-303. doi: 10.1007/s00439-018-1882-3. Epub 2018 Apr 24.